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ABSTRACT
Nitric Oxide is an important messenger and mediator in biological systems. Due to 
its short half life, S-nitrosothiols (RSNOs) have been suggested to be one of the 
important biomolecules for the storage and transport o f NO. RSNOs also exhibit NO-like 
bioactivities. In the present study, we focus on the study of some aspects of cell biology 
of lipid S-nitrosothiols.
In the first part o f the study, we focus on the comparison o f the cellular uptake of 
native LDL and chemically modified (homocysteinylation and S-nitrosation) LDL by 
Normal Human Fibroblasts (NHFs). Here, S-nitroso homocysteinylated LDL (LDL-SNO) 
was synthesized through the reaction of homocysteinylated LDL (LDL-SH) and S- 
nitrosocysteine. The effects of homocysteinylation and subsequent S-nitrosation on the 
uptake of LDL were examined in NHFs. The present results demonstrated that LDL-SH 
could be S-nitrosated to form LDL-SNO in vitro. Under our experimental conditions, 
homocysteinylation and subsequent S-nitrosation did not affect the specific uptake of 
LDL through LDL receptor mediated endocytosis. In addition, insulin exerts the same 
stimulatory effect on the uptake of chemically modified (homocysteinylation and S- 
nitrosation) LDL as that o f native LDL. These results suggested that S-nitrosation of 
LDL-SH might be a mild and favorable modification to reverse the detrimental actions of 
LDL-SH in atherosclerosis. The potential beneficial effects o f LDL-SNO in biological 
systems were discussed.
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In the second part of the study, we focus on the comparison of the role of lipid S- 
nitrosothiols in apoptosis under light and dark conditions. Here, S-nitroso- 
octadecanethiol, a novel and lipophilic S-nitrosothiol, was synthesized to explore its 
apoptotic role in the SK-MEL-28 human melanoma cells under dark and light conditions. 
The present study demonstrated that S-nitroso-octadecanethiol could induce apoptosis in 
SK-MEL-28 human melanoma cells. The apoptosis induced by S-nitroso-octadecanethiol 
involved the release of cytochrome C from mitochondria and caspase 3 activation. 
Furthermore, the apoptotic efficiency is substantially enhanced approximately 30% along 
with more cytochrome c released from mitochondria and higher caspase-3 activity upon 
exposure to the light with respect to dark condition. Therefore, the present study 
suggested that S-nitroso-octadecanethiol might have a potential to act as a 
photochemotherpeutic agent for melanoma.
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Part I
S-nitrosation of homocysteinylated low density lipoproteins 
and comparison of the uptake of native and modified 
(homocysteinylated and S-nitrosated) LDL by Normal Human
Fibroblasts
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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1.0 Abstract
Background and objectives: Oxidized low density lipoprotein (oxLDL) is a key element 
for the development o f atherosclerosis. Homocysteinylation o f LDL by homocysteine 
thiolactone (HcyTL) has been suggested to increase the susceptibility of LDL to 
oxidative modification. The extent of oxidation of homocysteinylated LDL (LDL-SH) 
has been shown to relate to the levels of free thiol groups incorporated into the LDL 
through the interaction with HcyTL (Ferretti et al., 2004). Nitric oxide (NO) is a good 
inhibitor for the oxidative modification of LDL. Protein thiol groups are the potential 
cellular targets for S-nitrosation reaction to form S-nitrosothiols (RSNOs), the most 
important biomolecules for the storage and transport of short-lived NO. RSNOs also 
possess NO-like bioactivities. Therefore, in the present study, whether free SH groups of 
LDL-SH could be susceptible to S-nitrosation to form favorable S-nitroso 
homocysteinylated LDL (LDL-SNO) was examined. Normal levels of LDL in plasma 
play a key role in vascular diseases such as atherosclerosis. Insulin plays a regulatory role 
in LDL homeostasis. Thus, the uptake of native LDL and chemically modified LDL 
(LDL-SH and LDL-SNO) by Normal Human Fibroblasts (NHFs) was compared. The 
effect o f insulin on the uptake of chemically modified LDL was also examined.
Methods: S-transnitrosation was used to study the nitrosation of LDL-SH. Fluorescently 
labeled LDL, LDL-SH and LDL-SNO with 3 ,3 ’-dioctadecylindocarbocarbocyanine (Dil) 
were used to compare the cellular uptake of native and chemically modified LDL.
Results and conclusions: LDL-SH could be S-nitrosated to form LDL-SNO in vitro. 
Under our experimental conditions, homocysteinylation and subsequent S-nitrosation did
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
not affect the specific uptake of LDL through LDL receptor mediated endocytosis. There 
is no significant difference among the uptake o f LDL, LDL-SH and LDL-SNO by NHFs. 
Insulin exerts the same stimulatory effect on the uptake of chemically modified 
(homocysteinylation and S-nitrosation) LDL as that of native LDL. These results 
suggested that S-nitrosation of LDL-SH might be a mild and favorable modification to 
reverse the detrimental actions of LDL-SH in atherosclerosis. The potential benefical 
effects o f LDL-SNO in biological systems are discussed.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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1.1 Introduction
1.1.1 Nitric oxide (NO) chemistry
NO is a small and hydrophobic molecule that is synthesized in biological systems 
(Moncada et al., 1991). It is one o f the most important signaling molecules in biological 
systems. It plays various roles in physiology and pathophysiology such as stimulation of 
vascular smooth muscle relaxation and atherosclerosis (Kerwin et al., 1995).The 
biological actions of NO are dependent on its chemical reactivity. Thus, understanding 
the chemical reactions o f NO in vivo is very important.
NO is a free radical which contains an unpaired electron. Therefore, in biological 
systems, NO will react with those substances that have unpaired electrons. Such typical 
examples include the reactions with oxygen (O2) and superoxide anion (O2* ). Another 
important reaction o f NO in biological systems is the interaction with metal complexes 
such as heme-containing protein soluble guanylate cyclase (sGC) (Krumenacker et al., 
2004).
1.1.1.1 Chemical reactions with O2
NO is unstable in an oxygen environment because it undergoes autooxidation. In 
the gas phase, the reaction of NO with O2 forms nitrogen dioxide (NO2) (Eq. 1.1.1) and 
dinitrogen trioxide (N2O3) (Eq.1.1.2).
2 NO + 0 2— ► 2 N02(1.1.1)
N02 + N 0 - * N 20 3 (1.1.2)
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
N 2O3 is responsible for the S-nitrosation reaction, the most important pathway for 
the formation o f the biologically important molecules such as S-nitrosothiols (RSNOs). 
However, in the aqueous phase, the resultant intermediate N 2O3 is not stable and 
undergoes hydrolysis to form nitrite (Eq. 1.1.3), which accounts for the short half- life of 
NO (reported to be only 0.1 seconds [Kelm et al., 1990]) (Wink et al., 1998).
N20 3+H20 — ► 2  H N 02 ( 1 .1 .3 )
NO and O2 are 9 times more soluble in hydrophobic solvents than in the water 
(Shaw et al., 1977; Malinski et al., 1993). Thus increased concentrations of NO and O2 in 
the hydrophobic phase can accelerate reaction o f NO with 0 2 up to 300- fold with respect 
to the aqueous phase (Liu et al., 1998). Therefore, it has been proposed that in biological 
systems the reaction of NO and O2 and subsequent S-nitrosation reactions mediated by 
N2O3 occur predominantly in the hydrophobic compartments such as lipid membranes, 
hydrophobic cores of the lipoproteins or protein interiors (Wink et al., 1998; Rafikova et 
al., 2 0 0 2 ).
1.1.1.2 Chemical reactions with superoxide anion (0 *2’)
The reaction of NO with 0*2‘ occurs at near diffusion controlled rates with a rate 
constant of 4.3 to 6.7 x l0 9M '1S‘ 1 to produce a powerful oxidant, peroxynitrite (ONOO') 
(Eq.1.1.4) (Beckman et al.,1996).
NO + 0 2'“  ► O N O O " ( 1 .1 .4 )
Peroxynitrite can undergo various chemical reactions. These reactions exhibit 
detrimental effects on biological systems. For example, once protonated, it will rapidly 
decompose to a potently cytotoxic intermediate-peroxynitrous acid (Beckman et al.,
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1996). Peroxynitrous acid has shown to mediate most of the oxidation and nitration 
reactions o f peroxynitrite (Koppenol et al., 1992). However, in vivo, the detrimental 
actions of peroxynitrite are greatly reduced due to the relatively high concentrations of 
reduced glutathiol (GSH) which exist in most cells (Wink et al., 1998). In addition, the 
reaction of peroxynitrite with CO2 produces a potent oxidizing and nitrating agent: 
nitrosoperoxycarbonate (ONO2CO2 ) (Lymar et al., 1995) which causes the tyrosine 
nitration seen in some pathological conditions such as Alzheimer's disease (AD) (Mayer 
et al., 1997; Reynolds et al., 2005.).
1.1.1.3 Chemical reactions with soluble guanylate cyclase (sGC)
A well-studied reaction of NO with metal complexes in biological systems is the 
reaction with soluble guanylate cyclase (sGC), one of the heme-containing proteins. 
sGC has been suggested to be the major receptor in vivo for NO (Denninger et al., 1999). 
Furthermore, the interaction of NO with sGC is one o f the most important mechanisms 
underlying the biological effects of NO. NO binds to the heme iron o f sGC at diffusion- 
controlled rates to form iron-nitrosyl complex (Mayer et al., 1997). The resultant iron- 
nitrosyl complex is pentacoordinate so as to activate sGC (Stone et al., 1995). Activation 
of sGC stimulates the production of an important second messenger cGMP, which is 
responsible for numerous physiological actions of NO such as vasodilation, anti-platelet 
aggregation and neurotransmission (Krumenacker et al., 2004).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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1.1.2 NO biochemistry
1.1.2.1 NO formation in biological systems
1.1.2.1.1 Enzymatic pathway for NO biosynthesis
It has been shown that NO synthesis in biological systems is catalyzed by a family 
of enzymes NO synthases (NOS). The reaction involves sequential oxidation of L- 
arginine to L-citrulline to produce NO, which utilize NADPH and O2 as cosubstrates. It 
also involves the formation of intermediate N-hydroxyl-L-arginine, which can act as a 







1 NADPH 0.5  NADPH
° 2 ° 2
+ N = 0
H3N COO' h 3n  c o o h 3n  c o o
L-Arginine N-hydroxy-L-Arginine L-Citrulline Nitric Oxide
Figure 1.1.1: Enzyme-catalyzed NO biosynthesis (Griffith et al., 1995)
1.1.2.1.2 Non-enzymatic pathway for NO synthesis
In addition to the most established pathway for enzymatic NO synthesis in 
biological systems, a recent study (Zweier et al., 1999) reported that enzyme-independent 
NO formation also occured in biological systems. Under acidic and highly reduced
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
conditions, NO can be generated in tissues by either direct disproportionation or 
reduction o f nitrite to NO. This pathway becomes the major source o f NO in important 
disease states such as ischemia or shock, where acidosis and marked hypoxia occur, 
although this pathway for NO synthesis can occur in all biological tissues.
1.1.2.2 NOS structure and function
Three NOS isoforms have been shown to be the products of separate genes 
(Nathan et al., 1994). Two of three NOS are constitutive enzymes known as neuronal 
NOS (nNOS) and endothelial NOS (eNOS) (Fleming et al., 1998). They synthesize NO 
in response to the increase of Ca in the cell. Another one is inducible NOS (iNOS). It 
synthesizes NO upon stimulation by signals such as cytokines (Kroncke et al., 1995; 
Hierholzer et al., 1998).
Although different isoforms, each NOS isoform monomer has a similar bidomain 
structure: a C-terminal reductase domain containing binding sites for NADPH, FAD, and 
FMN, and a N-terminal oxygenase domain for binding heme, tetrahydrobiopterin (H4B) 
and the substrate L-Arginine. Each domain can exist and function independently. An 
amino acid recognition sequence for the Ca 2 +- binding protein calmodulin (CaM) is 
located between the two domains (Hemmens et al., 1998) (Figure 1.1.2).
All three NOS isoforms are homodimeric enzymes (Stuehr, 1997). However, the 
interactions between oxygenase and reductase domains of the subunits are different for 
inducible NOS and constitutive NOS. Venema et al., (1997) reported that iNOS subunit 
association consists of only head to head interactions o f the oxygenase domains, 
however, eNOS and nNOS subunit association involves not only the oxygenase domain
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
interactions but also the reductase domain interactions as well as the interactions between 




L-Arg Fe H4 B
CaMFADCOOH





Figurel.1.2: Domain structure o f NOS homodimer, showing cofactor and substrate 
binding sites (Andrew et al., 1999).
1.1.2.2.1 NOS reductase domain structure
The NOS reductase domain has binding sites for FMN, FAD and NADPH (Stuehr 
et al., 1997). It has been suggested that the NOS reductase domain is homologous to other 
FMN- and FAD-containing reductases such as cytochrome P-450 reductase (Wang et al.,
1997). An isolated NOS reductase domain can transfer electrons from NADPH through 
the flavins FMN and FAD to cytochrome c as do cytochrome P-450 reductase (Gachhui 
et al., 1996; Chen et al., 1996). However, with respect to cytochrome P-450 reductase, 
CaM-binding domain is a requirement for the electron transfer of NOS reductase domain
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
(Abu-Sound et al., 1994), since Calmodulin activates not only intradomain electron 
transfer, but also interdomain electron transfer from NADPH via flavins to the heme, so 
as to contribute to the synthesis of NO (Abu-Sound et al., 1994; Stuehr et al., 1997).
1.1.2.2.2 NOS oxygenase domain structure
The human iNOS oxygenase domain structure is mainly exemplified as a model 
for studying the structure o f NOS isoforms oxygenase domains. Crane et al. (1997) 
reported that the human iNOS oxygenase domain has an elongated shape. It contains 
many (5-sheets, considerably different from those heme-containing oxygenases. It also 
contains a novel a-(5 fold. Therefore its structure is described to be analogous to a 
baseball glove with the heme group in the palm of the glove.
Zinc ion has been discovered to tetrahedrally coordinate to two pairs of cysteine 
(Cys) residues through the examination of the crystal structure of eNOS (Raman et al.,
1998). It has been proposed that zinc metal center functions as maintaining the integrity 
of H4B-bindig site. In addition, the zinc binding motif, Cys-(X) 4-Cys, is found to be 
conserved in all known NOS isoforms to date, suggesting that the zinc ion exits in all of 
physiologically relevant NOS structures. For example, zinc metal center has also been 
found to exist in human iNOS (Fischmann et al., 1999) and nNOS (Hemmens et al., 
2000). In addition to maintain the integrity of H4B-bindig site, a zinc metal center might 
favour dim er stabilization in iNOS (Li et al., 1999) and nNOS (H em m ens et al., 2000)
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1.1.2.3 Regulation of NOS activity
Although these three NOS isoforms can be regulated by differentially specific 
mechanisms, there are some regulation mechanisms that can be shared by all three NOS 
isoforms.
1.1.2.3.1 Feedback inhibition of NOS by NO
NO may be a negative feedback modulator of NOS. This is because NO can 
readily and reversibly bind the heme iron to form catalytically inactive Ferrous/Ferric- 
nitrosyl complex with NOS. Therefore, NOS enzymatic activity can be recovered only 
upon NO release from the heme iron (Hurshman et al., 1995; Abu-Soud et al., 1995). The 
extent of the inhibition of NOS enzymatic activity by NO is different for the different 
isoforms of NOS. It has been shown that ecNOS and nNOS are more susceptible to 
inhibition by NO than iNOS since NO has a higher reactivity toward heme in cNOS than 
iNOS (Wink et al., 1998). Moreover, the resultant Fe-NO complex is more stable in 
cNOS than iNOS.
1.1.2.3.2 H4B
NOS activity can be regulated by NOS cofactor H4B levels. H4B is essential for 
coupling O2 activation to NO synthesis (Mayer et al., 1995). The NOS homodimer has 
two binding sites for H4B which are located on each o f the two subunits. However, the 
binding of H4B to NOS showes strong negative cooperatives. The binding of the first 
H4B lowers the enzyme's affinity for binding the second H4B by at least an order of
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magnitude (Gorren et al., 1996). Thus insufficient H4B levels can limit NO biosynthesis 
(Harrison, 1997).
1.1.2.3.3 Calmodulin (CaM)
CaM is necessary for the enzymatic activities o f all three NOS isoforms, but 
functions differently in these three NOS isoforms. In eNOS and nNOS, CaM binding 
leads to the increase in the rate o f electron transfer from NADPH to the reductase domain 
flavins (Gachhui et al.; 1996 Gachhui et al., 1998.). At the same time, it also triggers 
electron transfer from the reductase domain to the heme center (Abu-Sound et al., 1994). 
Thus, CaM helps to increase the rate of NO synthesis caused by eNOS and nNOS.
However, for iNOS, CaM binding is not related to enzyme catalytic activity, but is 
essential to maintain the integrity of iNOS structures such as folding and stabilizing 
(Fossetta et al., 1996; Wu et al., 1996).
1.1.3 The physiological roles of NO in low density lipoprotein (LDL) peroxidation
NO has been characterized as an endothelium-derived relaxing factor (EDRF) 
(Gruetter, et al., 1979). The role of NO in vascular systems has been extensively explored. 
NO plays a key role in the stimulation of vascular smooth muscle relaxation (Ignarro, 
1989a; Ignarro, 1989b) and inhibition of platelet aggregation and adhesion through a 
cGMP-dependent mechanism (Furlong et al., 1987; Radomski et al., 1987). Any damage to 
the endothelial cell surface will affect the normal functions of NO in vascular systems, 
resulting in numerous pathophysiological disorders such as atherosclerosis (Ignarro et al.,
1999). Among the factors contributing to atherosclerosis, oxidized low density lipoprotein
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(oxLDL) is a key element (Napoli et al., 1997). NO has been suggested to be a good 
inhibitor for LDL peroxidation, thus reducing the possibility o f the development of the 
atherosclerosis initiated by oxLDL. However, NO regulates lipid peroxidation by a 
mechanism independent of cGMP (Bloodsworth et al., 2000).
1.1.3.1 Regulation of lipoprotein lipid peroxidation by NO
1.1.3.1.1 Mechanism of lipid peroxidation
Lipid peroxidation occurs as bis-allylic hydrogen of the unsaturated fatty acid is 
easily susceptible to be abstracted by initial free radicals to produce lipid free radicals (Eq. 
1.1.5). Lipid free radicals then react with oxygen to produce lipid peroxyl radicals. Lipid 
peroxyl radicals then propagate the lipid peroxidation since these radicals can oxidize 
adjacent unsaturated fatty acid to produce lipid hydroperoxide and a second lipid radical 
(Eq.1.1.7). Thus propagation of the lipid peroxidation (Hogg et al., 1999b; Ignarro 2000).
LH + R -— ► L + RH (Eq.1.1.5)
L - + o2  ^  LOO- (Eq.1.1.6)
LOO' +LH — ► L' +LOOH (Eq.1.1.7)
1.1.3.1.2 Mechanism of inhibition of the LDL peroxidation by NO
LDL is one o f the lipid-carrier blood lipoproteins. Its density ranges from 1.039 
g/ml to 1.062 g/ml. It comprises a non-polar core of triacylglycerols and cholesteryl esters,
surrounded by an amphiphilic coat o f phospholipids and cholesterol molecules and a single
molecule of apolipoprotein B-100 (Yoet et al., 1999a). About 50% of fatty acid molecules
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in the LDL are unsaturated, thus rendering LDL susceptible to oxidative modification 
(Esterbauer et al., 1992). LDL enters certain cell types by LDL-specific receptor-mediated 
endocytosis and is subsequently transported to the lysosomes for degradation (Brown et al., 
1979).
The most extensively examined mechanism for inhibition of LDL peroxidation by 
NO is the termination of the lipid peroxidation propagation reaction via scavenging of 
lipidperoxyradical (LOO*) (Eq. 1.1.8) (Rubbo et al., 1995; Goss et al., 1995; Goss et al., 
1997.)
LOO- + NO— ► LOONO (1.1.8)
Recent studies have shown that NO inhibits LDL peroxidation initiated by 
enzymatic or non-enzymatic pathways (Bloodsworth et al., 2000). For example, Rubbo 
(1995) demonstrated that pure NO gas can inhibit LDL peroxidation initiated by 
lipoxygenase. Hogg et al., (1993) reported that NO donor compounds S-Nitroso-N- 
acetylpenicillamine (SNAP) and sodium nitroprusside (SNP) could inhibit LDL
• • • 2 " b  * • • •peroxidation initiated by Cu . Termination o f lipid peroxidation propagation reaction by 
NO has been shown to protect the cells from the cytotoxicity induced by lipidperoxy 
radical (Wink et al., 1994; Wink et al., 1995).
NO is diffusible and lipophilic, and as a result it can diffuse into and concentrate in 
the hydrophobic core o f LDL as a lipophilic antioxidant for LDL (Denicola et al., 2002). It 
can react with lipid peroxyl radical (LOO’) at near-diffusion limited rates (k=l .0-3.0xl09M' 
'S '1) (Padmaja et al., 1993), 104-105 times higher than that of the reaction with a-tocopherol 
(Hogg et al., 1999b). a  -tocopherol is one of the low molecular weight lipophilic 
antioxidants present in LDL (Esterbauer et al., 1992). Therefore, NO can protect these low
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molecular weight antioxidants from oxidation (Goss et al., 1997) and act in synergy with 
these endogenous antioxidants to protect LDL from oxidation (Ignarro, 1989b; Rubbo et 
al., 2 0 0 2 ).
1.1.3.1.3 Mechanism of stimulation of the LDL peroxidation by NO
In contrast to its well-established direct role in protecting LDL from oxidation, NO 
can also promote LDL peroxidation indirectly by forming reactive nitrogen species such as 
powerful oxidant ONOO'. NO reacts with O2" at diffusion-limited rates [4.3 to 6.7 x l0 9M' 
to form peroxynitrite (ONOO'). ONOO' is such a powerful oxidant that it can directly 
initiate lipid peroxidation reactions by abstracting a hydrogen atom from a polyunsaturated 
fatty acid molecule (Darley-Usmar et al., 1992). It has been suggested that peroxynitrite 
can have free access to hydrophobic compartments in cells. Therefore, it can readily 
accumulate in the hydrophobic phase to regulate membrane and lipoprotein lipid oxidation 
reactions (Davis et al., 2001).
As mentioned above, NO can act as both antioxidant and prooxidant for lipid 
peroxidation. However, whether NO serves as antioxidant or pro-oxidant depends on the 
relative concentrations of NO and O2’ (Goldstein et al., 2000; Jourd’heuil et al., 2001; 
Rubbo et al., 2002). NO only stimulates peroxynitrite-induced lipid peroxidation when the 
concentration of NO is less than or equivalent to the concentration of O2'. If the 
concentration o f NO is more than that of O2', NO can inhibit peroxynitrite-induced lipid 
peroxidation (Rubbo et al., 1994). Therefore, NO could modulate LDL peroxidation in a 
concentration-dependent manner.
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1.1.4 S-nitrosothiols (RSNOs)
S-nitrosothiols are thiol-esters of nitrite. They have the generic structure R-S-N=0 
(Oae et al., 1983). RSNOs have long half-lives with respect to NO; they have been 
suggested to be one o f the important biomolecules in vivo for the storage and transport of 
NO (Stamler et al., 1992a). RSNOs also exhibit NO-like bioacitivities such as stimulation 
of smooth muscle relaxation, inhibition of platelet aggregation and adhesion (Stamler et al., 
1992a; 1992b). Therefore, understanding how RSNOs are formed in biological systems and 
their mechanisms of actions are of great importance.
1.1.4.1 Mechanism of RSNOs formation in biological systems
1.1.4.1.1 Oxygen-dependent route
RSNOs cannot be formed by the simple reaction of NO with free thiol groups. The 
reaction o f NO with thiols generates thiol disulfide rather than RSNOs (Eq. 1.1.9) 
(DeMaster ,1995).
NO+2RSH—*’RSSR+2NO+H+ (1.1.9)
The well-characterized mechanism for RSNO formation in biological systems is 
N2 0 3 -mediated S -nitrosation of free thiols (e.g. Glutathiol [GSH]). N 2O3 can be formed 
through autooxidation of NO (Kharitonov, 1995).
1.1.4.1.2 Nitrous acid-dependent route
RSNOs can be easily synthesized in the laboratory via the reaction between thiols 
and nitrite at acidic conditions (Eq. 1.1.10).
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HN02+RSH-^RSN0+H20  (1.1.10)
This route doesn’t occur at physiological pH (pH~7.0), and could only be relevant 
under extreme acidic conditions (pH< ~3) (Hogg, 2002).
1.1.4.1.3 Hydrophobic phase-dependent route
Actually, this route is crossed over with the oxygen-dependent route, but the 
hydrophobic interiors of protein (Nedospasov et al., 2000) and membranes (Liu et al.,
1998) may facilitate the formation of the nitrosating agent N2O3 from NO due to the 
enhanced solubility o f NO and O2 in the hydrophobic phase with respect to the water phase 
(Malinski et al., 1993; Shaw et al., 1997). Rafikova et al., (2002) reported that the 
hydrophobic phase of extracellular albumin catalyze the formation of RSNOs. The 
mechanism involves micellar catalysis of NO oxidation in the albumin hydrophobic core 
and specific transfer o f NO+to low-molecular-weight thiols.
1.1.4.2 Mechanism of biological action of RSNOs
1.1.4.2.1 NO release
1.1.4.2.1.1 Photodecomposition
RSNOs are photosensitive, especially to UV light. Irradiation o f  RSNOs leads to 
the homolytic cleavage o f the S-NO bond, resulting in the release of NO and formation of 
thiyl radicals (Eq. 1.1.11).
hv
R S N O  RS ’ + NO (1.1.11)
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For example, we have shown that irradiation o f S-nitrosoglutathione (GSNO) at 
340nm or 545nm results in the release of NO (Sexton et al., 1994). Singh et al. (1995) 
also demonstrated that irradiation of GSNO with light (X=550nm) resulted in the 
homolytic decomposition o f GSNO to generate NO and glutathionyl radical.
1.1.4.2.1.2 Metal-ion-catalyzed decomposition
RSNOs can be decomposed in a solution containing metal ions such as Cu+, 
Fe2+, Hg2+ and Ag+ (Williams et al., 1996a; Dicks et al., 1997).The well-studied 
decomposition of RSNOs catalyzed by metal ions is the reaction with copper ion. The 
possible decomposition mechanism catalyzed by copper ion is shown as follows (Figure 
1.1.3):
R S N 0 + H 20  ^  RS~ + N Q 2~ + 2H +
Cu2+ + RS '  Cu+ +RS ■
Cu+ + RSNO <  [Y ]------------ »► Cu2+ +RS ' + NO
2RS-  RSSR
h 2c — H2c  —
C N = °  CH " = °
\ /  /_\ J
N  Cu+ —  H ,0  0  N ^ u+ —  H20
t t
h2o  h 20
(A) (B)
Figure 1.1.3: RSNO decomposition catalyzed by copper ion (Wang et al., 2002)
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It has been suggested that Cu+ is the true effective catalyst, because the specific Cu+ 
chelator neocuproine stops the decomposition of RSNO completely (Williams, 1996b).
I j
Cu results from the reduction o f Cu by thiolate ion generated by hydrolysis of RSNO 
or free thiols. Cu+ catalyzes RSNO decomposition by forming a complex intermediate Y. 
Its structure is shown as A and B. Both Cu2+ and RS' can be regenerated and are present 
in catalytic quantities (Wang et al., 2002).
In addition, previous studies demonstrated that large concentrations of GSNO 
(e.g. ImM) are resistant to Cu - catalyzed decomposition. This is because oxidized 
glutathione (GSSG) is an effective copper ion chelator as shown in Figure 1.1.4. At 
higher GSNO concentration, GSSG is high enough to chelate Cu2+ to prevent the release 
of NO from GSNO. However, at lower GSNO concentration, GSSG is not enough to 
chelate Cu2+. Thus, Cu2+ promotes the NO release from lower concentrations of GSNO 
such as lpM  (Noble et al., 1999, Singh et al., 1999).
O
O
Figure 1.1.4: The structure o f complex of GSSG with Cu2+ (Noble et al., 1999)
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1.1.4.2.1.3 Reductant -dependent decomposition
Ascorbate and protein thiols such as Cys residues in the albumin have been 
demonstrated to promote the release of NO from RSNOs such as S-nitroso-albumin 
(ASNO) and GSNO. The mechanism involves the NO+ transfer to thiolate anion (RS') to 
form RSNO (Eq. 1.1.1-2). Subsequent release of NO from RSNO depends on a reductive 
activation o f NO+ (RSNO) to NO, which could be catalyzed by ascorbate monoanion 
(AH') or free thiol groups o f albumin (Eq. 1.1.13 & E q.l. 1.14). Compared with metal ion- 
catalyzed the release of NO from RSNO, ascorbate or protein thiols can cause only a 
slow release o f NO from RSNO (Scorza et al., 1997).
R'SNO+ RS ' RSNO+R'S ' (Eq.1.1.12)
RSH
RSNO === RSSR + NO (Eq.1.1.13)
RSNO +AH- === RSH + A +NO (Eq. 1.1.14)
1.1.4.2.1.4 Enzyme-catalyzed decomposition
Recent studies have shown several enzymes that can break down low molecular 
weight RSNOs in vitro. For example, Hogg et al. (1997) reported that GSNO can act as a 
substrate for y-glutamyl transpeptidase (y-GT), leading to the fonnation of S- 
nitrosocysteinyl glycine (CG-SNO) from GSNO (Figure 1.1.5). CG-SNO is more 
susceptible to transition metal ion-catalyzed decomposition to release NO with respect to 
GSNO. In addition, y-GT dependent decomposition of GSNO depends on the type of 
tissues, because this reaction occurs in the kidney, but not in the heart.







Figure 1.1.5: Proposed mechanism of y-GT-dependent GSNO decomposition (Hogg 
et al., 1997)
Trujillo et al., (1998) reported that xanthine oxidase (XO) can catalyze the 
decomposition o f low molecular weight RSNOs, such as GSNO and CysNO in an 0 {  - 
dependent or independent pathway to release NO. Glutathione peroxidase (GTx) has been 
implicated in the decomposition of GSNO to release NO (Freedman et al., 1995; Hou et 
al., 1996) Later, Liu et al. (2001) reported that glutathiol-dependent formaldehyde 
dehydrogenase is a GSNO reductase. Although it is specific for GSNO, it can affect the 
metabolism of other RSNOs such as S-nitrosylated protein. This enzyme is critical for 
RSNOs homeostasis and safeguards against nitrosative stress in biological systems.
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1.1.4.3 S-transnitrosation
S- transnitrosation refers to the transfer of nitroso group from a S-nitrosothiol to a 
thiol ( Eq. 1.1.15), more specifically, the nitrosyl (NO+) transfer from RSNO to the thiol 
target in the protein, peptides or amino acids so as to form a new R'SNO (Amelle et al., 
1995).
R S N O +R 'S H ^r R'SNO+RSH (Eq.1.1.15)
This reaction is a reversible second order reaction (Hogg, 1999a). It has been 
suggested that S-transnitrosation reactions may represent an important mechanism in vivo 
for the biological actions of RSNO (Park et al., 1993). In addition, S-transnitrosation 
reaction might be an alternative pathway for the release of NO from stable RSNO (Al- 
sa’doni et al., 2000). For example, recent studies demonstrated that transnitrosation 
reaction with low molecular weight thiols, such as L-cysteine, is required for the release
of NO from S-nitrosoalbumin (ASNO) and GSNO, because S-nitroso-cysteine (CySNO)
2 +
is easily subject to the decomposition catalyzed by Cu to release NO (Scharfstein et al., 
1994; Pietraforte et al., 1995).
1.1.4.4 5-thiolation
Thiol groups are also the targets for the 5-thiolation reaction. 5-thiolation may 
occur either by nucleophilic attack of sulfur of the RSNO by thiolate anion or by 
transnitrosation, followed by nucleophilic attack o f sulfur of the protein S-nitrosothiol. 
Both pathways for 5-thiolation result in the formation o f a mixed disulfide and nitroxyl 
anion (NO’) (Figure 1.1.6) (Konorev et al., 2000). 5-thiolation has been suggested to be a 
physiologically cellular response to the oxidative stress (Hogg, 2000). Recent study,
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however, demonstrated that S-thiolation may also be a cellular response to nitrosative 
stress (Padgett et al., 1998). Furthermore, it has been suggested that S-thiolation might be 
a thiol redox control mechanism for regulation o f protein by RSNOs (Ji et al., 1999; 
Konorev et al., 2000).







Figure 1 .1 .6:1: S-transnitrosation reaction 




II & III: S-thiolation reaction
1.1.4 Biological roles of RSNOs
RSNOs have been suggested to be the most important NO-carrier biomolecules 
for NO storage and transport. They exhibit NO-like activities through the release of NO 
such as being potent antiaggretary platelet agents (Radomski e t al., 1992) and
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vasodilators (Myers et al., 1990; Root et al., 2004). They also have a protective role in 
atherosclerosis by acting as an antioxidant for LDL peroxidation. Rigobello et al., (2002) 
reported that lipid peroxidation is remarkably decreased by GSNO, provided that copper 
ions, kept in reduced forms by ascorbate, are present. GSNO also protects endothelial 
cells from the cytotoxity exerted by oxLDL (Struck et al., 1995). These protective actions 
of RSNOs are attributed to the NO released from RSNOs (Rigobello et al., 2002; Struck 
et al., 1995).
RSNOs can also exert their biological function without the release of NO. They 
have been suggested to act as modulators of enzyme activity through the modification of 
protein thiols by S-transnitrosation or S-thiolation (Hogg, 2002). For example, Konorev 
et al (2000) reported that creatine kinase could be inacitivated through both S-nitrosation 
and 5-thiolation. S-nitroso-N-acetylpenicillaime (SNAP) predominantly modifies the 
thiol of creatine kinase by S-transnitrosation to form S-nitrosothiol. However, GSNO 
predominantly modifies the thiols of creatine kinase by S-thiolation. Therefore, the 
creatine kinase activity can be inhibited by both S-transnitrosation and S-thiolation of the 
thiol groups. Furthermore, it has been proposed that the relative extent of these reactions 
in biological systems depends on both the environment of the protein thiol and the 
chemical nature o f the RSNOs.
1.1.6 RSNOs transport across the membrane
RSNOs play an important role in many NO-mediated biological events. But how 
are RSNOs or their bound S-nitroso group transferred from the extracellular space into
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the cytosol or vise versa? To date, several mechanisms responsible for the RSNOs 
transmembrane transport have been proposed.
1.1.6.1 Cell-surface Protein Disulfide Isomerase (csPDI)-dependent manner
Protein Disulfide Isomerase (PDI) is an enzyme that catalyzes the thiol-disulfide 
exchange reaction (Voet et al., 1999b). Recently, PDI has been found to exist on the cell 
surface (Hotchkiss et al., 1998). Zai et al. (1999) proposed that cell surface PDI catalyzes 
transnitrosation reaction, facilitating NO entry into the cytosol from an extracellular 
RSNO source, thereby, promoting its intracellular bioactivity. Later, we demonstrated 
that csPDI catalyzes the NO release from RSNO; released NO then accumulates in the 
cell surface membrane where it can undergo autooxidation. The resultant intermediate 
N 2O3 was then nitrosation of intracellular thiols at the membrane-cytosol interface so as 
to transport extracellular -SNO functional group into the cytosol ( Ramachandran N. et 
al., 2001) (Figure 1.1.7).
Figure 1.1.7: Mechanism for S-nitrosation of intracellular thiol by csPDI catalyzed NO 
released from extracellular RSNOs (Ramachandran et al., 2001)
2RSNO 2RSH+2NO
csPDI
Membrane 2N 20 3
RSH RSNO
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1.1.6.2 System L amino acid transporter-dependent manner
System L amino acid transporter has been demonstrated to be involved in the 
transportation o f functional S-nitroso group from the outside o f the cell into the cytosol. 
For instance, Satoh et al. (1997) reported that S-nitroso-L-cysteine, an endogenous 
RSNO, is incorporated into rat brain slices via the system L amino acid transporter. Later, 
Nemoto et al. (2003) provided evidence that, in PC 12 cells, S-nitroso-L-cysteine was also 
incorporated via the system L amino acid transporter and thus regulates cell responses. 
Recent study demonstrated that L-cystine enhance GSNO-dependent S-nitrosothiol 
uptake via system L amino acid transporter in RAW 264.7 cells. They proposed that L- 
cystine firstly was reduced to L-cysteine, and then transnitrosation reaction occured 
between GSNO and L-cysteine to form S-nitroso-L-cysteine which was taken up by 
RAW 264.7 cells via amino acid transport system L (Zhang et al., 2004).
1.1.6.3 Anion exchanger-dependent manner
Stamler and coworkers ( Pawloski et al., 2001) proposed that export of 
hemoglobin-derived NO-bioactivity from the red blood cells was mediated by anion 
exchanger AE1 through the formation of anion exchanger AE1-SNO at the membrane- 
cytosol interface. Thus, anion exchanger AE1 might play a role in transmembrane 
translocation of NO bioactivity.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 7
1.1.7 Insulin resistance and endothelial dysfunction
1.1.7.1 Insulin
Insulin is a peptide hormone with the 5,700 molecular mass. It has two polypeptide 
chains which are joined by two disulfide bridges (Fig. 1.1.8). It is synthesized in the 
pancreas, it is an important signaling molecule for the maintaining the normal level of 
blood glucose concentrations, and its rate of secretion is increased in response to the higher 
levels of blood glucose (Nelson et al., 2000)
COO' V
ooc
Fig. 1.1.8 : Insulin structure
1.1.7.2 Physiological role of insulin in the vascular system
Insulin plays a central role in the regulation of glucose and fatty acid homeostasis. 
In addition to these traditional roles in energy metabolism, insulin has been suggested to be 
essential in the regulation of vascular tone. Previous studies have demonstrated that insulin
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can modulate vascular tone and tissue blood flow (Baron, 1994). It acts as a vasodilator via 
the activation o f eNOS to produce NO from the endothelium (Scherrer et al., 1994).The 
mechanism for the activation of eNOS mediated by insulin includes phosphorylation of 
eNOS and regulation of eNOS cofactor availability such as H4B (Mather et al., 2001).
1.1.7.3 Insulin resistance
Classical insulin resistance refers to the impairment o f insulin’s classic action to 
stimulate glucose uptake in skeletal muscle and fat cells (Kahn et al., 2000). However, it 
has been suggested that insulin-mediated NO release from the endothelium is also impaired 
in insulin resistant states such as Obesity and Type II diabetes mellitus (Steinberg et al., 
2002).
1.1.7.4 Endothelial dysfunction
The vascular endothelium is a dynamic organ that maintains the homeostasis of 
vascular system. It exhibits numerous physiological vasoprotective actions such as 
stimulation o f vascular smooth muscle cell relaxation, inhibition of platelet adhesion and 
aggregation etc. (Celermajer, 1997). These vasoprotective actions are mainly maintained by 
NO, endothelium-derived relaxing factor (Palmer et al., 1988). Therefore, endothelial 
dysfunction is characterized by decreased NO bioactivity (Cai et al., 2000). In addition, 
oxidized LDL has been suggested to be a main factor responsible for the disturbance of 
these normal endothelial functions (Dinerman et al., 1990). Loss o f these physiological 
endothelial functions is central in the development and progression of atherosclerosis
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(Adams et al., 2000). Thereby, oxidized LDL is an essential element in  the development of 
endothelial dysfunction and subsequent atherosclerosis.
1.1.7.5 Interaction of insulin resistance and endothelial dysfunction
A main reason for endothelial dysfunction is due to the loss of N O  bioactivity in the 
vessel wall: insulin resistance often results in the loss o f NO bioactivity (Tack et al., 1996). 
Therefore insulin resistance and endothelial dysfunction frequently coexist. A substantial 
body of evidence demonstrated that insulin resistance is tightly associated with endothelial 
dysfunction (Freeman et al., 2001; Baron et al., 1995).
1.1.8 LDL homocysteinylation and its role in vascular diseases
Previous studies demonstrated that elevated homocysteine (Hey) levels in the 
plasma are associated with human vascular diseases (Jacobsen, 1998). The mechanisms 
underlying the pathology o f the elevated Hey in the human vascular diseases are 
controversial. However, a recent study demonstrated that cytotoxity o f  Hey was related to 
Hey thiolactone (HcyTL) (Jakubowski, 1997).
HcyTL, a product o f Hey metabolized by methionyl-tRNA synthetase (MetRS) 
during protein systhesis (Jakubowski, 1995; Jakubowski, 1997), is chemically reactive 
towards primary amines via nucleophilic addition (Benesch et al., 1956). This reaction can 
equally occur in biological systems and has been suggested to be impicated in the vascular 
diseases. Jakubowski (1999) reported that under physiological conditions, proteins 
including LDL are easily subject to homocysteinylation by HcyTL; side chain amino 
groups of lysine residues are the major sites o f homocysteinylation in  proteins; chemical
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modification by HcyTL leads to protein damage, such as increased negative charge and 
electrophoretic mobility; formation of intermolecular disulfide bonds and protein 
multimers; protein precipitation etc. Thus, protein N-homocysteinylation might account for 
the damage effect o f Hey in the vascular diseases such as atherosclerosis.
Human plasma LDL, especially oxidized LDL, a key element in atherosclerosis, has 
also been demonstrated to be subject to homocysteinylation by HcyTL (Ferretti et al., 2003; 
Jakubowski et al., 2000). The resultant homocysteinylated LDL (LDL-SH) could increase 
the atherogenicity o f LDL. The possible explanations for the atherogenicity of 
homocysteinylated LDL could be categorized into two classes:
1-Homocysteinylation of LDL could increase the uptake o f modified LDL by 
macrophages with respect to native LDL. Higher uptake of homocysteinylated LDL leads 
to lipid accumulation in the macrophages, with the resultant formation of foam cells 
(Naruszewicz et al., 1994); 2-Homocysteinylation o f LDL by HcyTL potentiates its 
oxidation (McCully, 1993; Olszewski et al., 1993), which is a major factor for the 
development o f atherosclerosis (Yla-Herttuala et al., 1989; Steinberg et al., 1989; 
Steinberg, 1993). Furthermore, recent a study presented evidence that homocysteinylation 
of LDL induces a significant increase o f lipid peroxidation and oxidative damage on human 
vascular endothelial cells (EC). The extent of lipid peroxidation is proportional to the levels 
of SH groups. Thus, LDL-SH exerts a cytotoxic effect that is likely related to an increase in 
lipid peroxidation and oxidative damage of EC (Ferretti et al., 2004).
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1.2 Objectives
Oxidized low density lipoprotein (LDL) is a key element for the development of 
atherosclerosis. Homocysteinylation of LDL by homocysteine thiolactone occurs under 
physiological conditions. Homocysteinylation o f LDL by HcyTL has been suggested to 
be atherogenic since homocysteinylated LDL (LDL-SH) increased the susceptibility of 
LDL to oxidative modification. Furthermore, the extent o f oxidation has been shown to 
relate to the levels o f free thiol groups incorportated into the LDL through the interaction 
with HcyTL. NO plays a protective role in atherosclerosis by serving as a potent inhibitor 
of LDL oxidation. In addition, thiol groups in the protein have been suggested to be 
cellular targets for S-nitrosation. S-nitrosation of thiols promotes the formation of S- 
nitrosothiols (RSNOs). RSNOs have shown NO-like bioactivities. Therefore we wanted 
to examine whether LDL-SH could be S-nitrosated in vitro to form favorable S-nitroso 
homocysteinylated LDL (LDL-SNO) so as to block the reactivities of the free thiol 
groups o f LDL-SH. Maintaining the normal levels of human plasma LDL is fundamental 
to the prevention of the development of vascular diseases such as atherosclerosis. 
Therefore, whether chemical modifications such as homocysteinylation and S-nitrosation 
affect the LDL uptake was also examined. Finally, insulin has been suggested to 
physiologically stimulate LDL uptake. Thus, we also want to investigate whether 
homocysteinylation and S-nitrosation affect the actions of insulin on LDL uptake.
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1.3 Materials and Methods
1.3.1 Materials
3, 3'-dioctadecylindocarbocyanine (Dil) was purchased from Molecular Probes, Inc. 
(U.S.A.). DL-Homocysteine thiolactone (HcyTL), 5,5’-Dithiobis(2-nitrobenzoic acid 
(DTNB), 2,3-diaminonaphthalene (DAN), Sodium nitrite, Potassium bromide, Copper 
sulphate, Sodium hydroxide, Hydrogen chloride, Sodium phosphate, Sodium chloride, 
Ethylenediaminetetraacetic acid (EDTA), Dimethyl sulfoxide (DMSO), Methanol, 
Insulin, Cysteine, Sephadex G-25, Fetal bovin serum (FBS) were purchased from Sigma 
Chemical Co.(St. Louis Mo.). Normal human fibroblasts (NHFs) were obtained from the 
American Type Culture Collection (Rockville, MD, USA).
1.3.2 Methods
1.3.2.1 Preparation of LDL
Human LDL was prepared from the blood of individual healthy volunteers. The 
plasma fraction is obtained by low-speed centrifugation of the whole blood for 15min. 
Lipoproteins were isolated by Sequential Flotation Ultracentrifugation (Verne et al., 
V128).Briefly, human plasma density (1.006 g/ml) was first adjusted to 1.019g/ml with 
potassium bromide (KBr). In order to prevent oxidation 0.01% EDTA was present during 
the isolation procedure. After centrifugation at 40,000rpm for 24h at 10°C using a fixed- 
angle rotor (Ti60) and Model L8 -M ultracentrifuge (Beckman, Palo Alto, CA). The top 
fraction that contains a mixture of very low-density lipoproteins (VLDL) and 
intermediate-density lipoprotein (ILDL) was discarded. The bottom fraction (whose
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initial density is assumed to be 1.019g/ml) is then adjusted to a final density of 1.063 
g/ml with solid KBr and centrifuged again as before, and LDL fraction (1.019-1.060 
g/ml) was collected. LDL preparation was extensively dialyzed against lOmM phosphate, 
137mM NaCl, 0.01% EDTA (pH7.4) for 36h at 4° C, filter-sterilized (0.45pm, Fisher) 
and its final protein concentration was determined as described by Bradford (Bradford 
MM, 1976).
1.3.2.2 Fluorescent Labeling of LDL with 3, 3'-dioctadecylindocarbocyanine (Dil)
LDL was labeled with the fluorescent probe Dil as described by Pitas RE (Pitas et 
al., 1981).Briefly, 15mg of LDL were added to 30ml o f lipoprotein-deficient serum and 
then filter-sterilized, using 0.45pm filter. To the lipoprotein, 750pl o f  Dil (3mg/ml) in 
dimethyl sulfoxide (DMSO) was added, while the solution was gently vortex-mixed, and 
the sterile mixture was incubated at 37°C for 18 hours. Then the density of the incubation 
mixture was raised to 1.060 g/ml with KBr, and Dil-LDL was isolated as LDL. The Dil 
labeled LDL was then dialyzed against lOmM phosphate, 137mM NaCl, and 0.01% 
EDTA (PH7.4) for 36h at 4°C, filter-sterilized (0.45pm, Fisher) and its final protein 
concentration was determined as described by Bradford (Bradford, 1976).
1.3.2.3 Homocysteinylation of LDL by homocysteine thiolactone
The LDL was homocysteinylated as previously described (Ferguson et al., 1999). 
5mM homocysteine thiolactone (HcyTL) was added to 2mg/ml of LDL protein solution. 
An aliquot o f solution mixture was passed through a Sephadex G-25 column equilibrated 
with lOmM PBS, pH 8.2 every 20 min to separate the unreacted HcyTL. Thiol groups (-
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SH) were determined with Ellman’s reagent (DTNB) (Packer, V.233). The 
concentrations o f SH groups coupled to LDL are given in terms o f moles per mole LDL 
protein.
1.3.2.4 S-nitrosation of homocysteinylated LDL (LDL-SH)
1.3.2.4.1 Sythesis of S-nitroso-Cysteine
S-nitroso-cysteine (CySNO) was prepared as previously described (DeMaster et 
al., 1995). Cysteine (Cys) in 2M HC1 was incubated with an equimolar concentration of 
sodium nitrite in the dark for 30 min at 25°C. The solutions were then neutralized with 
2M NaOH and lOmM phosphate buffer (pH 7.4).
1.3.2.4.2 Synthesis of S-nitroso homocysteinylated LDL (LDL-SNO)
LDL-SNO was prepared by incubation of 1 mg/ml LDL-SH with 6 mM CySNO in 
lOmM PBS containing 500pM EDTA at 37°C for 60 min and protected from light. The 
solution was eluted on a Sephadex G-25 gel filtration column with lOmM PBS 
containing 500pM EDTA to separate the LDL-SNO from the excess CysNO.
1.3.2.5 Determination of the concentrations of NO groups coupled to LDL-SH
The concentrations of NO groups coupled to LDL-SH were quantified as 
previously described (Jourd’heuil D et al., 2000).Briefly, nitrosating agent produced from 
the Cu2+-catalyzed decomposition of the S-nitrosothiol is trapped by 2,3- 
diaminonaphthalene(DAN) to form the highly fluorescent derivative 2,3 napthotriazole
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(NTA), which allows determination o f nitrites (NO2’). Because LDL-SNO is degraded in 
the presence o f Cu2+ ions, the difference between the NO2’ level in the presence and 
absence of Cu2+ ions allows the measurement of the NO level o f LDL-SNO. 500pi of the 
sample was added to 1.0ml o f redistilled water and 500pl o f DAN reagent mixture, which 
was prepared by the addition o f 1.1 ImM CUSO4 and 15.8mM DAN in 0.62M HC1 at 1:4 
ratios. The samples were incubated at room temperature in the dark for 10 min. To stop 
the reaction, the samples were alkalized to pH 12 by the addition o f 10M NaOH. 
Fluorescence measurements were performed at excitation wavelength 362 nm and 
emission wavelength 406nm.
1.3.2.6 Fluoresence microscopy
To localize the uptake o f fluorescent liporoteins, cell cultures were preincubated 
with medium containing 10% lipoprotein-deficient serum (LPDS) for 24h before the 
addition of Dil-LDL, Dil-LDL-SH, and Dil-LDL-SNO. Cells were incubated with 
different concentrations of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO for 30min at 37°C. 
Cells were then washed three times with PBS containing 0.5% BSA and three times with 
PBS alone. Cells were then changed back to fresh medium for the determination of 
intracellular fluorescence intensity. Uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO 
by cells was observed with the aid of a Zeiss Axiovert 200 fluorescence microscope with 
a 20 x fluoresence objective. The intracellular fluorescence intensity was measured by 
computer-assisted image analysis (Northern Eclipse 6.0).
To determine the effects of insulin on the uptake of Dil-LDL, Dil-LDL-SH and 
Dil-LDL-SNO, cells were pretreated with various concentrations o f insulin for 24 h
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before incubating with Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO. The following 
experimental steps were performed as described above.
1.3.2.7 Cell culture
NHFs were cultured in Iscove's Modified Dulbecco's Medium (IMDM) 
supplemented with 10% fetal bovine serum (FBS) and penicillin streptomycin Solution as 
antibiotics. Cells were maintained in a humidified incubator at 37°C in 5% C0 2 /9 5 % air.
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1.4 Results
1.4.1 Kinetics of homocysteinylation of LDL by homocysteine-thiolactone
Previous studies demonstrated that LDL could be homocysteinylated by HcyTL 
(Ferretti G et al., 2004). In the present study, it was necessary to establish a reproducible 
homocysteinylation protocol and to determine the degree of LDL homocysteinylation in 
order to study the extent o f S-nitrosation of homocysteinylated LDL as well as the effect 
of homocysteinylation on the LDL receptor-mediated uptake o f  LDL by NHFs. 
Therefore, the kinetics of thiol (SH) groups coupling to human LDL were carried out in 
the reactions between HcyTL and LDL. Figure 1.4.1 demonstrated that incubation of 
human LDL with HcyTL resulted in a time-dependent increase in SH groups covently 
bonded to human LDL.
Homocysteinylation occurs by aminolysis of the thiolactone bond of HcyTL. 
Thereby, the new homocysteine residue becomes attached through a peptide bond to the s 
nitrogen of apo-B lysine residues to form homocysteinylated LDL (LDL-SH) adduct 
(Eq. 1.4.1) (Vidal et al., 1986; Ferguson et al., 1999).
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The SH level was determined by Ellman’s reagent (DTNB). As shown in Figure 
1.4.1, exposure o f LDL to HcyTL for 40min resulted in around 37.5 mol SH/mol LDL 
protein. In the present study, 18% modification of LDL lysine residues (i.e. 40 min of 
exposure o f LDL to HcyTL) was used in subsequent studies.This is in view of a previous 
study which demonstrated that lysine residues of apo-B are functional groups for the 
binding o f LDL to the cell surface LDL receptor; furthermore, chemical modification of 
more than 20% of the lysine residues of LDL prevents the LDL from binding directly to 
the LDL-specific receptor (Weisgraber et al., 1978).
1.4.2 S-nitrosation of LDL-SH
A recent study demonstrated that LDL-SH was involved in the development of 
atherosclerosis, probably due to an increase in lipid peroxidation, and that, the extent of 
lipid oxidation is directly related to the levels of SH groups in LDL-SH (Ferretti et al., 
2004). NO is shown to be an effective antioxidant for lipid peroxidation. In addition, 
RSNOs are potent reservoirs for NO in vivo and potentiate its biological effects. 
Therefore, we examined whether SH groups in LDL-SH could be S-nitrosated in vitro. 
Presumably, LDL-SNO possesses NO-like properties such as stimulation of smooth 
muscle cell relaxation, inhibition of platelet aggregation and adhesion, inhibition of LDL 
peroxidation, and thus would reduce the possibility o f the atherosgenesis induced by 
LDL-SH.
LDL-SNO was synthesized by the S-transnitrosation of LDL-SH with CySNO, 
physiological RSNO. LDL-SNO formation was detected based upon the formation of 
fluorometric compound naphthotriazole (NTA). NTA is formed by the reaction of 2, 3-
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diaminonaphthalene (DAN) with NO released from S-nitrosylated proteins in the 
presence o f metal ion such as Cu2+, thus providing a quantitative measure of S- 
nitrosothiol formation (Jourd’heuil et al., 2000). The result demonstrated that significant 
LDL-SNO was formed (Figure 1.4.2). Based on the SH level (37.5mol/ mol LDL protein) 
of LDL-SH, we calculated that approximately 55% of SH groups o f LDL-SH were S- 
nitrosated by CySNO, suggesting that LDL-SH could be S-nirosated in vitro under the 
present experimental conditions.
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Figure 1.4.1: Kinetics of homocysteinylation of human LDL by HcyTL. The reaction 
mixtures containing human LDL (2 mg of protein per ml) and 5mM HcyTL were kept at 
present variable room temperature for the indicated periods. At the indicated times, 
aliquots o f solution were passed through Sephadex G25 to remove excess HcyTL. The 
levels of the SH groups coupled to human LDL were determined by Ellman’s reagent 
DTNB (e = 13,600 M 'W 1). Those values marked with an asterisk (*) are statistically 
significant (p<0.05).





Figure 1.4.2: S-nitrosation of LDL-SH by CySNO. After 40 min homocysteinylation 
reaction, 6 mM CySNO was added into purified LDL-SH solution in the presence of 
500pM EDTA, and was stirred for lh  in the dark, then passed through Sephadex G25 
column to remove excess CySNO. The level o f NO groups coupled to LDL-SH was 
determined by DAN assay as shown in Methods. Asterisk (*) indicated statistically 
significant values (p<0.05).
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1.4.3 Fluorescent labeling of LDL, LDL-SH, and LDL-SNO with D il
LDL had to be fluorescently labeled in order to monitor its uptake by Normal 
Human Fibroblasts(NHFs) with the aid o f fluorescence microscope. LDL was 
fluorescently labeled with Dil as previously described (Pitas et al., 1981). Under the 
present experimental conditions, LDL was successfully labeled by D il because NHFs 
have strong fluorescence as shown in Figure 1.4.3 after taking up Dil-LDL in the absence 
of 100 fold unlabeled LDL, but NHFs almost have no fluorescence after taking up Dil- 
LDL plus 100 fold unlabeled LDL (at the same settings of fluorescence microscope). 
This indicated that strong intracellular fluorescence observed after incubation with Dil- 
LDL alone is the result o f specific uptake of Dil-LDL via the LDL receptor pathway. In 
the present study, Dil-LDL-SH was prepared by homocysteinylation of LDL that had 
been previously labeled with Dil. Dil-LDL-SH was then subjected to  the S-nitrosation 
reaction to get Dil-LDL-SNO.
1.4.4 Comparison of the uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO
1.4.4.1 Time course of uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO
The effects o f homocysteinylation and subsequent S-nitrosation on the uptake of 
LDL by NHFs were examined. Time course o f uptake o f Dil-LDL, Dil-HcyLDL and Dil- 
LDL-SNO by NHFs was first examined. NHFs were incubated at 37°C with Dil-LDL, 
Dil-LDL-SH and Dil-LDL-SNO at a concentration of 5pg protein /m l for the indicated 
times as shown in Figure 1.4.4 and then analyzed for fluorescence intensity at indicated 
times by fluorescence microscope.
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As shown in Figure 1.4.4, NHFs became fluorescent after only 10 min of 
incubation. The uptake o f Dil-LDL by NHFs was linear and rapid during the first 30 min 
of incubation. After that, there was a slower rate of uptake over the next 60 min while the 
uptake approached saturation. Moreover, the pattern o f time course uptake of Dil-LDL- 
SH and Dil-LDL-SNO was similar to that o f uptake o f Dil-LDL. 30 min was therefore 
chosen as the optimal incubation time for Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO in 
the following experiments.
1.4.4.2 The effect of various concentrations on the uptake of Dil-LDL, Dil-LDL-SH
and Dil-LDL-SNO by NHFs
NHFs were incubated with 2, 4, 8 , 16, 30pg/ml Dil-LDL, Dil-LDL-SH and Dil- 
LDL-SNO respectively at 37°C for 30min. NHFs were then analyzed for fluorescence 
intensity to make a comparison among the uptake of Dil-LDL, Dil-HcyLDL and Dil- 
LDL-SNO by NHFs. As shown in Figure 1.4.5, the uptake o f Dil-LDL by NHFs 
displayed a typical hyperbolic curve. At lower concentrations (<16pg/ml), uptake of Dil- 
LDL was linearly related to the concentrations o f Dil-LDL, Uptake, however, approached 
saturation at higher concentrations of LDL (>16pg/ml). This was consistent with LDL 
receptor-mediated process. Furthermore, the pattern of uptake of Dil-LDL-SH and Dil- 
LDL-SNO was similar to that o f Dil-LDL, suggesting that homocysteinylation and 
subsequent S-nitrosation did not affect the uptake of LDL by NHFs.
In addition, to quantitatively confirm that there is no significant difference among 
the uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO by NHFs, we calculated the Km 
for the uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO according to the double-
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reciprocol plot of Figure 1.4.5 (Figure 1.4.6). The Km for the uptake of Dil-LDL, Dil- 
LDL-SH and Dil-LDL-SNO was found to be 4.8, 4.9 and 5.0 respectively suggesting that 
under the present experimental conditions, the uptake o f LDL by NHFs has no significant 
change after chemical modifications (homocysteinylation and subsequent S-nitrosation).
The above results suggested that chemical modification o f lysine residues of 
apolipoprotein (apo)-Bioo of LDL by HcyTL and further S-nitrosation of LDL-SH by 
CySNO did not affect the uptake of LDL by NHFs.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4 5
Figure 1.4.3 Visual detection o f uptake o f Dil-LDL by NHFs. NHFs were preincubated 
for 24h in DMEM with 10% lipoprotein-deficient serum (LPDS). NHFs were then 
incubated for 30min with Dil-LDL (4pg/ml) (a) in the absence or (b) in the presence of 
100 fold unlabeled LDL in the same medium. NHFs were then washed three times with 
PBS containing 0.5% BSA and again three times with PBS alone prior to examination by 
fluorescence microscopy.
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Figure 1.4.4: Time course uptake of Dil-LDL, Dil-LDL-SH, and Dil-LDL-SNO by 
NHFs. NHFs were preincubated for 24h in DMEM with 10% lipoprotein-deficient serum 
(LPDS). NHFs were incubated with 5ug/ml Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO at 
37°C for lOmin, 30min, lh, 2h, 3h and 4h. NHFs were washed three times with PBS 
containing 0.5% BSA and again three times with PBS alone prior to examination by 
fluorescence microscopy.
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Figure 1.4.5: Comparison of uptake of various concentrations o f Dil-LDL, Dil-LDL-SH 
and Dil-LDL-SNO by NHFs. NHFs were preincubated for 24h in DMEM with 10% 
lipoprotein-deficient serum (LPDS). NHFs were then incubated with Dil-LDL, Dil-LDL- 
SH and Dil-LDL-SNO at concentrations of 2, 4, 8 , 16, 30 pg/ml for 30min at 37°C. 
NHFs were then washed three times with PBS containing 0.5% BSA and again three 
times with PBS alone prior to examination by fluorescence microscopy.
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Figure 1.4.6: A double-reciprocal plot of Figure 1.4.5.
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1.4.5 Uptake of Dil-LDL-SH and Dil-LDL-SNO by LDL-specific receptor pathway
In order to determine whether the uptake o f chemically modified LDL (LDL-SH 
and LDL-SNO) is specificially through LDL receptor-mediated process, NHFs were 
coincubated respectively with 4pg/ml Dil-LDL, Dil-LDL-SH, Dil-LDL-SNO and 100 
fold unlabeled LDL at 37°C for 30 min, then analyzed for fluorescence intensity of the 
cells. As shown in Figure 1.4.7, strong fluorescence was observed when NHFs were 
incubated with Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO without unlabled LDL. 
Fluorescence, however, could not be detected under the same settings of fluorescence 
microscope when the NHFs were incubated with Dil-LDL, Dil-LDL-SH and Dil-LDL- 
SNO plus 100 fold unlabeled LDL (Figure 1.4.8), suggesting that uptake o f LDL-SH and 
LDL-SNO was almost completely blocked by excess native unlabeled LDL; uptake of 
LDL-SH and LDL-SNO was via LDL-specific receptor pathway.
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Figure 1.4.7: Uptake of Dil-LtJL, Dil-LDL-SH and Dil-LDL-SNO by NHFs. NHFs 
were preincubated for 24h in DMEM with 10% lipoprotein-deficient serum (LPDS). 
Then NHFs were incubated with Dil-labeled 4pg/ml LDL, LDL-SH and LDL-SNO at 
37°C for 30min. NHFs were then washed three times with PBS containing 0.5% BSA 
and again three times with PBS alone prior to examination by fluorescence microscopy. 
Phase contrast and fluorescence microscopic views o f the same fields are shown.
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Figure 1.4.8: Competitive inhibition o f uptake o f Dil-LDL, Dil-LDL-SH and Dil-LDL- 
SNO by unlabeled LDL. NHFs were preincubated for 24h in DMEM with 10% 
lipoprotein-deficient serum (LPDS). NHFs were coincubated with Dil-labeled 4pg/ml 
LDL, LDL-SH and LDL-SNO and 100 fold unlabeled LDL at 37°C for 30min. NHFs 
were then washed three times with PBS containing 0.5% BSA and again with PBS alone 
for another three times prior to examination by fluorescence microscopy. Phase contrast 
and fluorescence microscopic views o f the same fields are shown.
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1.4.6 Comparison of the effects of insulin on the uptake of Dil-LDL, Dil-LDL-SH  
and Dil-LDL-SNO by NHFs
Insulin has been shown to play a regulatory role in maintaining the normal levels 
of LDL in the plasma. Furthermore, it has been reported that insulin caused the 
enhancement of uptake of LDL through LDL receptor-mediated endocytosis in NHFs 
(Chait et al., 1978). In order to determine whether chemical modification of LDL affects 
the role o f insulin in the LDL uptake, the uptakes of Dil-LDL, Dil-LDL-SH and Dil- 
LDL-SNO by NHFs were compared with and without 50nM insulin. As shown in Figure 
1.4.9, Figure 1.4.10 and Figure 1.4.11, LDL receptor mediated endocytic uptakes of Dil- 
LDL, Dil-LDL-SH and Dil-LDL-SNO by NHFs were all enhanced in the presence of 
50nM insulin. Moreover, the patterns of the increase in the uptake o f Dil-LDL, Dil-LDL- 
SH and Dil-LDL-SNO were similar, suggesting that chemical modifications have no 
significant effect on the role of insulin in the stimulation of uptake of LDL by NHFs.
Dose effects of insulin on the uptake of Dil-LDL, Dil-HcyLDL and Dil-LDL- 
SNO by NHFs were also examined (Figure 1.4.12). As shown in Figure 1.4.12, the 
pattern of uptake o f native Dil-LDL is quite similar to that of the uptake of Dil-LDL-SH 
and Dil-LDL-SNO in the presence of various concentrations of insulin. Uptake of Dil- 
LDL, Dil-LDL-SH and Dil-LDL-SNO increased with increased concentration of insulin 
up to 50nM, and then gradually declined.
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Figure 1.4.9: Comparison of the uptake of Dil-LDL by NHFs with and without 50nM 
insulin. NHFs were preincubated for 24h in DMEM with 10% lipoprotein-deficient 
serum (LPDS). NHF cells were then incubated with various concentrations of Dil-LDL 
with and without 50nM insulin at 37°C for 30min. Then NHFs were washed three times 
with PBS containing 0.5% BSA and again three times with PBS alone. NHFs were 
analyzed for fluorescence intensity to compare the difference of uptake of Dil-LDL in the 
presence and absence of 50nM insulin. Those values marked with an asterisk (*) are 
statistically significant(p<0.05).
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Figure 1.4.10: Comparison of the uptake o f Dil-LDL-SH by NHFs with and without
50nM insulin. NHFs were preincubated for 24h in DMEM with 10% lipoprotein-deficient
serum (LPDS). NHF cells were then incubated with various concentrations of Dil-Hcy-
with and without 50nM insulin at 37°C for 30min. Then NHFs were washed three times
with PBS containing 0.5% BSA and again three times with PBS alone. NHFs were
analyzed for fluorescence intensity to compare the difference of uptake of Dil-LDL-SH
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Figure 1.4.11: Comparison of the uptake of Dil-LDL-SNO by NHFs with and without
50nM insulin. NHFs were preincubated for 24h in DMEM with 10% lipoprotein-deficient
serum (LPDS). NHFs were then incubated with various concentrations o f Dil-LDL-SNO
with and without 50nM insulin at 37°C for 30min. Then NHFs were washed three times
with PBS containing 0.5% BSA and again three times with PBS alone. NHFs were
analyzed for fluorescence intensity to compare the difference of uptake o f Dil-LDL-SNO
in the presence and absence of 50nM insulin. Those values marked with an asterisk (*)
are statistically significant (p<0.05).
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Figure 1.4.12: Comparison of the effects o f  various concentrations of insulin on the 
uptake of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO by NHFs. NHFs were preincubated 
for 24h in DMEM with 10% lipoprotein-deficient serum (LPDS). NHFs were also 
pretreated with various concentrations of insulin overnight. NHFs were then incubated 
with 5pg/ml Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO at 37°C for 30min. NHFs were 
washed three times with PBS containing 0.5% BSA and again three times with PBS 
alone. NHFs were analyzed for fluorescence intensity to compare the difference of uptake 
of Dil-LDL, Dil-LDL-SH and Dil-LDL-SNO in the presence of various concentrations of 
insulin.
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1. 5 Discussion
Homocysteinylation o f lysine residues o f ApoB in LDL is a physiologically 
relevant modification of LDL by HcyTL. This modification might promote atherogenic 
ability o f LDL because previous studies demonstrated that LDL homocysteinylation 
increased the uptake o f LDL by macrophage in cultures and therefore contributed to the 
formation of foam cells (Naruszewicz et al., 1994). LDL-SH is more subject to oxidative 
modification, resulting in a cytotoxic effect on human vascular endothelial cells (Ferretti 
et al., 2004).These processes can lead to the development of atherosclerosis. In addition, 
LDL homocysteinylation has been suggested to be immunogenic and specific for HcyTL 
modified lysine residues (Ferguson et al., 1999). Although the mechanism of how LDL- 
SH mediates these processes is unclear, the extent of damage to the cells is related to the 
incorporation of Hey into the LDL, and more specifically, related to the free -SH groups.
NO has been suggested to be an endothelium-derived relaxing factor. It plays a 
functional role in the control of vascular tone (Maxwell et al., 1998). NO also plays a 
protective role in atherosclerosis by serving as a potent inhibitor o f LDL oxidation 
(Rubbo et al., 2002), which is a key step for the development o f atherosclerosis (Chisolm 
et al., 2000). However, the half life of NO has been reported to be only 0.1 second in vivo 
(Kelm et al., 1990). Therefore, SH groups in amino acids, peptides and proteins in 
biological systems have been suggested to play a key role in stabilizing shorted lived NO 
by forming S-nitrosothiols (RSNOs). RSNOs have been suggested to be, in plasma and 
cellular milieux, stable NO-carrier molecules that preserve NO biological activities such 
as vasodilation and antiplatelet properties (Stamler et al., 1992a). In addition, Stamler and 
coworkers (Stamler et al., 1992b) also reported that RSNOs circulate in plasma primarily
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as S-nitrosoproteins because they have long half-lives under physiological conditions 
compared with free nitric oxide or S-nitrosothiol adducts o f low-molecular-weight thiols.
As shown in the present results, an increase of the free thiol groups is a 
characteristic o f LDL-SH. LDL-SH was S-nitrosated in vitro through the S- 
transnitrosation o f LDL-SH by CySNO. Here S-transnitrosation not S-nitrosation by NO 
itself was used because exogenous thiols (homocysteinyl residues) o f LDL-SH have been 
demonstrated to expose to the aqueous phases o f LDL (Ferguson et al., 1999); CysNO 
was hydrophilic. Furthermore, Tsikas et al. (2001) reported that S-transnitrosation of 
albumin by CysNO could be a more favorable mechanism for the formation of S- 
nitrosoalbumin in the circulation in vivo than S-nitrosation of albumin by NO itself. 
Therefore LDL-SH could be S-nitrosated in plasma through the S-transnitrosation to 
form S-nitrosoprotein, LDL-SNO, under physiological conditions. The resultant LDL- 
SNO might reverse the detrimental effects of LDL-SH on biological systems. For 
instance, it could prevent LDL-SH from aggregation because S-nitroso groups block the 
reactivity o f free -S H  groups so as not to readily form protein multimers which are 
responsible for the aggregation of LDL-SH. Blocking the reactivity o f  free -SH  groups 
might also reduce the immunogenicity of LDL-SH because immune response is specific 
to Hcy-Lys-epitopes (Ferguson et al., 1998). In addition, it is possible that LDL-SNO 
could be antiatherogenic by preventing oxidative modification o f LDL. Therefore, S- 
nitrosation of LDL-SH could be physiologically relevant and favorably alter the 
detrimental effects of LDL-SH on biological systems.
It has been established that LDL is taken up through LDL receptor-mediated 
endocytosis in human fibroblasts (Brown et al., 1976). Fibroblasts are a common model
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5 9
used in the study o f lipid metabolism (Zimmermann et al., 2001). In addition, HcyTL has 
been found to be synthesized in human fibroblasts (Jakubowski, 1997). Therefore, we 
chose normal human fibroblasts (NHFs) as a model to examine whether 
homocysteinylation and subsequent S-nitrosation affect the uptake o f LDL through high 
affinity LDL receptor-mediated endocytosis by NHFs.
The data presented here demonstrate that time and dose courses o f uptake of 
LDL-SNO and LDL-SH are similar to those o f uptake of native LDL. Moreover, uptake 
of LDL-SH and LDL-SNO was almost completely inhibited by excess unlabeled native 
LDL. These results suggest that chemical modifications including homocysteinylation 
and subsequent S-nitrosation do not affect uptake o f LDL by NHFs; LDL-SNO and LDL- 
SH are taken up specifically via LDL receptor pathway by NHFs. Thus, the uptake of 
LDL-SNO through LDL receptor-mediated enocytosis might have an important 
biological application for the delivery of the functional group -SNO  from the 
extracellular space into the cytosol. This might also represent a new pathway in vivo for 
transport o f RSNO into the cytosol from extracellular space.
Insulin may stimulate the uptake of plasma LDL. This has been observed in 
human skin fibroblasts and hepatic cells HepG2 (Chait et al., 1978; Wade et al., 1988). 
However, it is not known whether chemical modifications (homocysteinylation and 
subsequent S-nitrosation) o f LDL affect the role o f insulin in the regulation of LDL 
uptake. The present data demonstrate that homocysteinylation and S-nitrosation does not 
change the stimulatory affect of insulin on LDL uptake. However, in a state of insulin 
resistance, the action of insulin on the stimulation of plasma LDL uptake is impaired 
(Steinberg et al., 1997). Thus, the LDL plasma levels are elevated; LDL may be
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
metabolized by vascular endothelial cells. With the consumption of endogenous 
antioxidants in LDL such as a  tocopherol by vascular endothelial cells, oxidative 
modification o f LDL will occur, thus leading to the development o f atherosclerosis 
(Adams et al., 2000). Moreover, LDL-SH potentiates LDL oxidative modification 
(Ferretti et al., 2004). These adverse effects might be reversed through uptake of LDL- 
SNO by vascular endothelial cells, because NO is not only an effective EDRF but also a 
good inhibitor for LDL oxidation. In addition, the stimulation of NO production through 
the endothelium by insulin is also impaired in insulin-resistance state. Insulin-resistance 
state often result in the endothelial dysfunction due to the decreased NO bioactivity. 
Thus, uptake o f LDL-SNO by vascular endothelial cells might also improve endothelial 
dysfunction in insulin-resistance state. Therefore formation o f LDL-SNO in vivo might 
have a significant biological role in insulin resistance state.
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1.6 Conclusion
The present results demonstrated that human LDL is homocysteinylated by 
HcyTL to produce LDL-SH. LDL-SH is S-nitrosated to form LDL-SNO in vitro. 
Furthermore, homocysteinylation and subsequent S-nitrosation, under the present 
experimental conditions, did not affect the specific uptake of LDL through LDL receptor 
mediated endocytosis. In addition, homocysteinylation and subsequent S-nitrosation did 
not change the effect o f insulin in the stimulation of LDL uptake by NHFs. Thus, 
chemical modification (Homocysteinylation and S-nitrosation) might not affect the LDL 
homeostasis. S-nitrosation of LDL-SH might reverse the detrimental effect o f LDL-SH in 
biological systems. Uptake of LDL-SNO through LDL receptor-mediated endocytosis 
might be an alternative pathway for delivery of RSNO into the cells from the 
extracellular space. Uptake of LDL-SNO might also have an important biological 
application in insulin resistance state. O f course, whether LDL-SH could be S-nitrosated 
to form LDL-SNO in vivo and its beneficial effects on biological systems remain to be 
proven in the future studies.
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Part II
Apoptosis induced by S-nitroso-octadecanethiol in SK-MEL-28 
human melanoma cells is enhanced by light exposure
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2.0 Abstract
S-nitrosooctadecanethiol (ODTSNO), a novel S-nitrosothiolipid, was prepared by 
the reaction o f 1-octadecanethiol with /-butylnitrite. The apoptotic role of ODTSNO in 
SK-MEL-28 human melanoma cells under the dark and light conditions was examined.
The present results demonstrated that ODTSNO could induce apoptosis in SK- 
MEL-28 human melanoma cells as assessed by typical morphological features of 
apoptosis such as chromatin condensation and DNA fragmentation. The apoptosis 
induced by S-nitroso-octadecanethiol involves the release of cytochrome c from 
mitochondria and caspase 3 activation. Furthermore, the apoptotic efficiency is 
substantially enhanced approximately 30% upon exposure to the light compared to the 
dark condition. The amount of cytochrome C released from mitochondria in the presence 
of light was more than that in the dark; the activity of caspase-3 upon exposure to the 
light is approximately 1.4 fold higher than that o f caspase-3 in the dark.
The present study suggests that S’-nitrosothiollipids have the potential to be used 
as topical photochemotherapeutic agents for melanoma.
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2.1 Introduction
2.1.1 Terminology of apoptosis
Apoptosis, or programmed cell death (PCD), is a highly regulated and energy- 
dependent process (Hengartner, 2000). Morphologically and biochemically, it is 
characterized by membrane blebbing, chromatin condensation, cell shrinking, and 
nucleus fragmentation (Kerr et al., 1972). Caspase, aspartate-directed cysteine protease, 
has been suggested to be a central executioner for these morphological and biochemical 
changes (Hengartner MO, 2000). Thus, caspase activation plays a key role in apoptosis. 
Caspase activation likely initiates by two distinct pathways: an extrinsic/death receptor 
pathway and an intrinsic/ mitochondrial pathway (Reed et al., 2000; Zimmerman et al., 
2001).
2.1.2 Apoptotic pathways
2.1.2.1 Extrinsic/ Death receptor-linked apoptotic pathways
This apoptotic pathway requires the specific binding of a ligand to a cell surface 
death receptor to initiate caspase activation. Death receptor includes Fas, tumor necrosis 
factor receptor 1(TNFR 1). The death receptor-linked apoptotic pathway can be 
exemplified by the interaction of Fas ligand (FasL) and Fas death receptor (Fig 2.1.1). 
The binding o f FasL to Fas death receptor leads to the recruitment of FADD (Fas- 
associated protein with death domain) to the Fas death receptor via the DD (death 
domain) interaction. Procaspase-8 is then recruited to the FADD, thus resulting in the
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formation o f  DISC (death-inducing signaling complex). The procaspase 8 is 
autocatalyzed at DISC to form a mature and active enzyme caspase 8. The apoptotic 
caspase cascade was then initiated by the active caspase 8 (Reed et al., 2000; Zimmerman 
etal., 2001).
2.1.2.2 Intrinsic apoptotic pathway
This pathway involves release of multiple polypeptides from mitochondria. The 
most studied polypeptide is cytochrome c, an electron transport chain protein, which 
accumulates in the cytoplasm when released from mitochondria (Figure 2.1.2). In the 
cytoplasm, cytochrome c binds to the scaffolding protein Apaf-1 (apoptotic protease- 
activating factor-1), leading to the formation of Apaf-1 oligomers. Procaspase-9 then 
binds to the Apaf-1 oligomers to form apoptosome (high molecular mass complex) 
(Strasser et al., 2000; Hengartner, 2000). Activated caspase-9 then proteolytically 
activates caspase-3. Activated caspase-3 then mediates the apoptotic cascades (Kaufmann 
et al., 2001).
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Figure 2.1.1: Induction of apoptosis by the interaction of FasL with Fas receptor. The 
interaction of FasL with Fas leads to the recruitment of FADD to the death domain of 
Fas, then procaspase 8 is recruited to FADD, forming DISC (death-inducing signal 
complex). Procaspase 8 is then autoacitivated to mature and active enzyme caspase-8 to 
initiate apoptotic caspase cascades (Zimmerman et al., 2001).
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Figure 2.1.2: Induction of apoptosis via the mitochondria pathway. Cellular stress 
induces pro-apoptotic Bcl-2 fam ily m em bers to translocate from  the cytosol to the 
mitochondria, where they induce the release of cytochrome c. Cytochrome c catalyzes the 
oligomerization of Apaf-1, which recruits procaspase-9and promotes its activation. This, 
in turn, activates procaspase-3, leading to apoptosis (Zimmermann et al., 2001)
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2.1.3 Apoptotic pathways mediated by NO
NO has been suggested to be an effector molecule for macrophage mediated 
tumor cell death. Furthermore, NO mediated tumor cell death meets the morphological 
and molecular criteria o f apoptosis (Albina et al., 1998). Therefore, studies have been 
undertaken to explore the role of NO in apoptosis. For example, many studies 
demonstrated that NO can induce apoptosis in various cell types such as macrophage cell 
lines (Messmer et al., 1995), thymocytes (Sandau et al., 1996), chondrocytes (Blanco et 
al., 1995), mesangial cells (Sandau et al., 1997), neurons (Lipton et al., 1993), vascular 
endothelial cells (Lopez-C et al., 1997), smooth muscle cells (Nishioet al., 1996), various 
tumor cells (Lorsbach et al.,1993) etc. Although there are different apoptotic mechanisms 
in different cell types, several general pathways for apoptosis induced by NO have been 
established. These pathways are the mitochondria-dependent/intrinsic apoptotic 
pathways.
2.1.3.1 Direct activation of mitochondria apoptotic pathway
NO can promote apoptosis via a direct effect on mitochondria by the opening of 
the permeability transition pore (PTP) (Green et al, 1998). Upon the opening of PTP, 
apoptotic protein cytochrome c is released from mitochondria into the cytosol to trigger 
apoptosis (Liu et al, 1996).
It has been suggested that the mitochondria inner membrane is an important site 
acted upon by NO (Shiva et al., 2001). In the mitochondria inner membrane, NO can 
reversibly bind to and inhibit the cytochrome c oxidase of the mitochondria respiratory
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enzymes, resulting in the generation of reactive oxygen species, such as superoxide anion 
(O2O
(Poderoso et al., 1996). The near diffusion-controlled reaction between NO and O2’ 
produce peroxynitrite (ONOO‘), a highly cytotoxic agent (Cadenas e t al., 2000). It has 
been suggested that mitochondria ATP synthase and aconitase can be irreversibly 
inhibited by peroxynitrite. It also can cause the opening of permeability transition pore, 
cytochrome c release and caspase-3 activation to initiate apoptosis (Brown, 1999).
Indeed, previous studies have shown that ONOCT can induce apoptosis in various types 
of cell lines, such as HL-60 cells (Yabuki et al, 1997), canine cerebral vascular muscle 
cells (Li, 2003) and human colon carcinoma cells (Kim et al, 2004).
2.1.3.2 MAPK (Mitogen-activated protein kinases) signalling pathways
2.1.3.2.1 MAPKs
MAP kinase is an essential part of the cellular phosphorylation/de­
phosphorylation signalling cascades. It plays a central role in cell growth, differentiation 
and programmed cell death (Chang et al., 2001). Mammalian MAPKs can be classified 
into at least 3 groups, each containing isoenzymes: [1] extracellular signal-related kinases 
(ERK1/2); [2] c-Jun N-terminal Kinases (JNK1/2/3); [3] p38 kinases (p385 a /p / y) 
where, JNK and p38 kinases are often described as stress activated protein kinases 
(SAPKs) because they are usually activated by a number of environmental stressors such 
as UV irradiation, heat shock and osmotic shock. Therefore, SAPKs are often associated 
with apoptosis, whereas ERK Vz are typically associated with cell survival (Davis, 2000).
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2.1.3.2.2 MAPKs activation by NO
M APK’s activation has been suggested to be involved in mediating NO induced 
apoptotic signals (Lander, 1996). However, the role o f MAPK’s activation in the NO 
induced apoptosis is complex, depending on the types of NO donor and the cells 
examined. For example, Callsen et al. (1999) reported that GSNO promoted apoptosis in 
RAW 264.7 macrophages with the activation of ERK1/2, JNK1/2 and p38. However, 
ERK1/2 activation is anti-apoptotic signal, whereas JNK1/2 activation is a pro-apoptotic 
signal and p38 activation is independent of GSNO-induced apoptosis in macrophages. 
While in another study with the same cell type, SNAP was used as NO donor, p38 and 
JNK1/2 were activated, but ERK1/2 was not activated. P38 activation is responsible for 
the apoptosis whereas JNK1/2 activation is unrelated to apoptosis (Jun et al., 1999). In 
yet another study SNAP induced apoptosis in the human Jurkat cells, all of three MAPKs 
were activated (Lander et al., 1996). These studies suggested that MAPKs activation and 
the role of MAPKs activation in the NO induced apoptosis are specific to the type of NO 
donors and cells examined.
How does MAPK’s signal pathway stimulate pro-apoptotic protein release from 
mitochondria and consequently lead to apoptosis? Tournier et al., (2000) reported that 
activation of JNK, one of the stress-activated protein kinases, is required for 
mitochondria cytochrome c release and subsequently downstream activation of caspase-9 
and -3 to in itiate  apoptosis. Several studies have demonstrated that the molecular 
mechanism responsible for cyctochrome c release induced by JNK activation may 
involve regulation o f the state of the Bcl-2 protein family such as down-regulation of the
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anti-apoptotic Bcl-2 and Bcl-xl proteins and upregulation of the pro-apoptotic Bax and 
Bad proteins;.or phosphorylation of Bcl-2 and Bcl-xl by JNK (Choi, 2000; Fan, 2000).
2.1.3.3 p53-dependent apoptotic pathway
p53 activation is likely involved in NO-induced apoptosis. p53 activation is the 
consequence of DNA damage caused by NO (Messmer et al., 1994). p53 activation 
during NO-induced apoptosis has been observed in various cell types such as RAW 264.7 
macrophages (Messmer et al., 1994), RINm5F cells (Messmer et al., 1996), breast cancer 
MCF-7 cells (Mortensen et al., 1999), astrocytes (Yung et al., 2004) etc. p53 activation is 
partly due to the DNA damage induced by NO (Messmer et al., 1994), or activation of 
JNK pathway leading to the phosphorylation of p53, thereby resulting in the stabilization 
of tumor suppressor p53 protein and subsequent increase of p53 levels (Buschmann et al., 
2001).
2.1.4 Antiapoptotic effect of NO
NO has been suggested to be a double-edged sword. In addition to its pro-apoptotic 
effect, NO can also be anti-apoptotic. One explanation for this is that NO is a potent 
antioxidant free-radical scavenger (Hogg et al., 1998) and may suppress apoptosis by 
removing pro-oxidant molecules through radical-radical termination reaction. An 
alternative explanation for this is that S-nitrosylation of active site cysteine residues of 
caspase-3, a central executioner for the apoptosis, results in the inhibition of its activity, 
and consequent inhibition of apoptosis (Mannick et al., 1999).
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2.2 Objective
RSNOs may release NO by photochemically homolytic cleavage o f the S-NO 
bond (Singhet al., 1995). The role o f photolysis o f RSNOs in the cytotoxity of the tumor 
cells has been explored in our several studies. For example, we have shown that 
photolysis o f  GSNO resultes in the enhanced cytotoxity in the HL-60 human leukemia 
cells. The enhanced cytotoxity results from the NO released from photolysis of GSNO 
(Sexton et al., 1994). We also demonstrated that photolysis of GSNO is able to induce 
specific cell death in human Tenon’s capsule (TC) fibroblasts (Tannous et al., 2000). 
Thus, RSNO could be used as a photochemotherapeutic agent in cancer therapy through 
the delivery o f high and toxic concentrations o f NO into the site of interest (Hogg, 2000).
Therefore, in the present study, a novel and lipophilic RSNO, S-nitroso-thiollipid 
was synthesized to explore its apoptotic effect on SK-MEL-28 human melanoma cells 
upon exposure to the light
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2.3 Materials and Methods
2.3.1 Materials
1-Octadecanethiol, Tert-butyl nitrite, Hoechst 33258, Phenylmethylsulfonyl fluoride, 
Pepstatin A, Pepstain B, DEVD-AFC and Griess reagent (N-(l-naphthyl)ethylenediamine 
dihydrochloride and Sulfanilamide), Fetal bovine serum (FBS) and Horseradish 
peroxidase were purchased from Sigma-Aldrich ( St.Louis Mo). SK-MEL-28 human 
melanoma cells were purchased from ATCC (ATCC number HTB-72).
Monoclonal anti-mouse cytochrome C antibody was from Santa Cruz Biotechnology Inc. 
lxPhosphate buffered saline (PBS)-137mM NaCl, 12.7mM KC1, lOmM Na2H P 04, and 
1,76mM KH2P 0 4, PH 7.4
2.3.2 Methods
2.3.2.1 Synthesis of S-nitrosooctadecane thiol (ODTSNO)
1-octadecanethiol (LSH) was dissolved in chloroform. Equimolar tert-butyl nitrite 
was added and reaction was carried out in the dark at room temperature for 5 min. The 
concentration o f ODTSNO produced was determined by measuring the absorbance at 
340nm (s34onm=980 M '1cm '1) (DeMaster et al., 1995).
2.3.2.2 Preparation of ODTSNO liposomes
50ul ODTSNO solution in chloroform was added into an ependorf centrifuge 
tube, 1ml lxPBS was then slowly layered on the top of ODTSNO solution and sonicated
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for 5 min at room temperature. The liposome suspension formed in the PBS layer was 
transferred to another tube and diluted to the desired concentration.
2.3.2.3 Nitrite Assay
NO undergoes a series o f reactions with several molecules present in biological 
fluids. The final products of NO in vivo are nitrite and nitrate. The sum of nitrite and nitrate 
can be the index o f total NO production. Nitrite, a stable NO oxidation product, was 
determined using the Griess reaction. First, nitrate was converted to nitrite utilizing nitrate 
reductase. Then 50pi experimental sample was added to wells in triplicate. 50pl of 1% 
Sulfanilamide in 5% phosphoric acid was first added to the experimental samples and 
incubated lOmin at room temperature in the dark. 50pi o f 0.1% NED (N-\- 
napthylethylenediamine dihydrochloride) in water was then added to the experimental 
samples and incubated for lOmin at RT in the dark. Nitrite was thus converted into a deep- 
purple azo compound. The absorbance of the azo chromophore was measured at 540nm 
using a microplate reader () to determine nitrite concentrations of the samples against a 
sodium nitrite standard curve.
2.3.2.4 Western blot analysis for cytochrome c released from mitochondria
Cells were scraped and harvested, washed twice with ice-cold PBS. Cells were 
then resuspended in a lysis buffer (2mM HEPES, 5mM MgCl2, ImM EGTA and 1% 
Triton X-100) containing a protease inhibitor mixture (O.lmM phenylmethylsulfonyl 
fluoride, 5pg/ml pepstatin A, and lpg/m l pepstain B) and placed on ice for lOmin. Cells 
were then homogenized and centrifuged at 15,000 g for 15 min at 4°C to make cytosolic
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fractions for detecting cytochrome c release from mitochondrial. Same amount of Protein 
samples (20pg) were mixed with an equal volume of 2x SDS sample buffer, boiled for 5 
min, and then separated through 14% SDS-PAGE gels. Protein samples were then 
transferred to nylon membranes by electrophoretic transfer. The membranes were 
blocked in 5% skim milk in TBST (20mM Tris-HCl, 200mM NaCl and 0.2% Tween) for 
lh, rinsed, and incubated with anti-cytochrome c monoclone primary antibody 
(l:1000dilution) overnight at 4°C. Primary antibody was removed by 3 xlOmin with 
TBST. Horseradish peroxidase (HRP)-conjugated anti-mouse secondary antibody 
(1:2000 dilution) was then added and incubated for lh  at RT with gentle shaking. 
Secondary antibody was removed by repeated washes as described for primary antibody. 
Blots were developed using the 3, 3’-diaminobenzidine substrate for immunocoupled 
HRP and bands were visualized with Alpha Innotech Corporation Imaging System. The 
protein concentration was determined by the Bradford assay.
2.3.2..5 Measurement of Caspase- 3 activity
Caspase-3 activity was determined in the cytosolic extracts by the fluorometric 
assay. Cytosolic extracts were prepared by the centrifugation o f the cell lysates at 
15,000g for 15min. The supernatants were incubated in caspase assay buffer [lOOmM 
Hepes (pH 7.5), 10% (w/v) sucrose, 0.1% CHAPS, ImM EDTA, lOmM dithiothreitol in 
the presence of fluorochromic caspase substrate DEVD-AFC for lh  at 37°C. The increase 
in fluorescence as a result o f AFC release was monitored at 505nm and caspase activity 
was expressed in fluorescence intensity/per mg of protein/min.
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2.3.2.6 Cell culture
SK-MEL-28 human melanoma cells were purchased from ATCC (ATCC number 
HTB-72). The SK-MEL-28 melanoma cells were cultured in ATCC medium: Minimum 
essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain
1.4 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 90% of 1.0 mM 
sodium pyruvate,; 10% of fetal bovine serum and incubated at 37°C in a humidified 
atmosphere containing 5% CO2 and 95% air. Exponentially growing skin cancer cells 
were seeded at lxlO 6 per six-well plate, and then the cells were exposed to various agents 
indicated in the results part.
2.4.7 Hoechst staining
Cells were stained with Hoechst dye (5pg/ml) for 5min, washed and examined 
under fluorescence microscopy at 365nm excitation wavelength and 465nm emission 
wavelength. The percentage of apoptotic cells was determined by counting the number of 
nuclei showing chromatin condensation and fragmentation characteristic of apoptosis.
2.4.8 Light source
Overhead projector with the power of 300W was used as visible light source for 
treating the cells throughout the experiments.
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2.4 Results
2.4.1 Instability of ODTSNO liposome upon exposure to the light
ODTSNO was synthesized as described in Methods. To determine the optimum 
duration of photolysis o f ODTSNO liposome, the absorbance of ODTSNO at 340nm 
before and after exposure to the light was measured at the indicated exposure time as 
shown in Figure 2.4.1. ODTSNO liposome is relatively stable in the absence of light 
within 30min. In contrast, ODTSNO liposome is substantially decomposed in the 
presence of visible light within 30min. For example, about 80% of ODTSNO liposome 
was decomposed upon exposure to the light for 15 min. Therefore, 15min was used as 
exposure time in the present study in order to avoid potentially adverse effect of longer 
exposure to the light on the cells.
2.4.2 Uptake of ODTSNO liposomes
To determine the required duration for the SK-MEL-28 human melanoma cells to 
take up ODTSNO liposome, ImM ODTSNO liposome was added to the cells and 
incubated for various durations, then nitrite production in the cytosolic extraction was 
measured. As shown in Figure 2.4.3, the more nitrite, the longer the incubation time. 
However, uptake o f ODTSNO liposome by Sk-MEL-28 human melanoma cells reached 
saturation after 30min incubation. In contrast, intracellular [NO2 ] o f  cell incubated with 
ODT remained constant for the duration o f the experiment. Thus, 30 min was used as 
incubation time of ODTSNO liposome for the SK-MEL-28 human melanoma cells in the 
following experiments.
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Figure 2.4.1: Photolysis of ODTSNO liposome. 500uL of 780pM ODTSNO liposome 
and 500 uL PBS were combined in each of ten vials. Five vials were exposed to light, the 
other five vials were kept in the dark. At the indicated exposure times, absorbance at 
340nm was measured by extraction of ODTSNO liposome with 1ml chloroform to 
determine the stability o f ODTSNO liposome upon exposure to the light. Those values 
marked with an asterisk (*) are different from controls with statistical significance 
(p<0.05).
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Figure 2.4.3: Nitrite production from ODTSNO liposome. The SK-MEL-28 human 
melanoma cells were incubated with ImM ODTSNO liposome for the different lengths 
of time; excess liposomes were then removed. Cells were changed back to fresh medium. 
The cytosolic nitrite production in the medium was assayed as described in Methods. 
Those values marked with an asterisk (*) are different from controls with statistical 
significance (p<0.05).
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2.4.3 Comparison of apoptosis induced by ODTSNO in the presence and absence of 
light in SK-MEL-28 human melanoma cells
NO is potently cytotoxic to tumor cells in vitro (Hibbs et al., 1988). Furthermore, 
previous studies have shown that NO can induce apoptosis in various types of cells 
including tumor cells. Much of this work has been performed with chemical NO donors, 
such as RSNOs. RSNOs as an NO donor have a biological relevance since they represent 
a storage form of NO in biological systems (Kolb, 2000). RSNOs have been suggested to 
be potential photochemotherapeutic agents for cancer. For example, we have shown that 
photolysis o f  GSNO resulted in an enhanced cytotoxic effect o f GSNO on HL-60 
leukemia cells (Sexton et al., 1994).
In the present study, we synthesized a novel and hydrophobic RSNO, S-nitroso- 
octadecanethiol (ODTSNO), to explore its apoptotic effect on SK-MEL-28 human 
melanoma cells upon exposure to the light.
SK-MEL-28 human melanoma cells were exposed to 2mM ODTSNO liposome 
for 30min. Excess ODTSNO liposome was then removed and the cells were changed 
back to fresh medium. One plate of SK-MEL-28 human melanoma cells in the fresh 
medium was exposed to the overhead projector for 15min; another plate of cells was kept 
in the dark. Both plates of cells were then put back to incubator for 24 hours before the 
examination o f the apoptotic effect of ODTSNO on SK-MEL-28 human melanoma cells. 
As shown in Figure 2.4.4 (A), SK-MEL-28 human melanoma cells treated by ODTSNO 
with and without light exhibit morphological apoptotic features such as membrane 
blebbing, chromatin condensation, and DNA fragmentation, compared with untreated and
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1-octadecanethiol (ODTSH) treated cells. In addition, as shown in figure 2.4.4 (B) the 
percentage o f  apoptosis induced by ODTSNO in the presence of light in SK-MEL-28 
human melanoma cells was approximately 65%, compared to approximately 30% in the 
absence of light.
In order to confirm that the observed apoptotic effects were due to NO and not to 
the chemical carrier moiety ODTSH, we repeated the experiments using an equimolar 
concentration of ODTSH. The results demonstrated that ODTSH had no effect on the 
apoptosis o f  SK-MEL-28 human melanoma cells under dark and light conditions, thereby 
confirming the apoptotic role o f NO released from ODTSNO in SK-MEL-28 human 
melanoma cells. In addition, in order to rule out the possibility that the apoptotic effect is 
partly due to the light itself, we also controlled the experiments using cells treated only 
with light. As shown in Figure 2.4.4 (B), light does not account for the apoptosis of SK- 
MEL-28 human melanoma cells, suggesting that the increase o f apoptotic efficiency in 
the presence of the light is attributed to the higher concentrations o f  NO released from 
ODTSNO with respect to the cells treated by ODTSNO without light.
Treatment o f SK-MEL-28 human melanoma cells with various concentrations of 
ODTSNO resulted in a concentration-dependent induction of apoptosis. Furthermore, 
apoptotic efficiency is higher in the presence o f light than in the absence of the light at all 
the concentrations examined (Figure 2.4.5). In addition, SK-MEL-28 human melanoma 
cells apoptosis induced by ODTSNO was time-dependent, with apoptotic percentage 
much higher in the presence of the light than in the absence of the light at all the times 
examined (Figure 2.4.6).
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These results demonstrated that ODTSNO, a novel NO-donor compound of 
RSNOs, could induce apoptosis in SK-MEL-28 human melanoma cells as do other 
RSNOs such as GSNO. Furthermore, the apoptotic efficiency was greatly enhanced in the 
presence o f  light, suggesting that higher concentrations o f NO were released by 
photolysis o f  ODTSNO with respect to the dark conditions; ODTSNO might have a 
potential to act as topical photochemotherapeutic agents for melanoma.
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Figure 2.4.4: Apoptosis induced by ODTSNO in the presence and absence o f light in 
SK-MEL-28 human melanoma cells
A-Legend
(I) SK-MEL-28 human melanoma cells were incubated with medium alone (II) SK-MEL- 
28 human melanoma cells were treated with LSH. (Ill) SK-MEL-28 human melanoma 
cells were treated with ODTSNO. All the cells were stained with Hoechst dye 33258, and 
examined by a fluorescence microscope.
B-Legend
SK-MEL-28 human melanoma cells were grown in 6-well plates and treated with 2mM 
ODTSNO liposome for 30min; excess ODTSNO liposome was removed. The cells were 
then exposed to the light for 15min and put back to the incubator for 24h. Apoptosis was 
determined by hoechst stain assay. Those values marked with an asterisk (*) are different 
from controls with statistical significance (p<0.05).
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Figure 2.4.5: Dose-dependent apoptosis induced by ODTSNO under dark and light 
conditions. Cells were treated with various concentrations o f ODTSNO liposome for 
30min, and then exposed to light for 15min. The cells were changed back to fresh 
medium and put back to incubator for 24h. Apoptosis was determined by Hoechst stain 
assay as described in Methods. Those values in the presence o f light that are different 
from those in the dark with statistical significance (p<0.05) are marked with an asterisk 
(*)•
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Figure 2.4.6: Time course o f the ODTSNO-induced apoptosis in SK-MEL-28 human 
melanoma cells under dark and light conditions. SK-MEL-28 human melanoma cells 
were treated by ImM of ODTSNO liposome for 30min, and then exposed to light for 
15min. The cells were changed back to fresh medium and put back to incubator. 
Apoptosis was then determined at the indicated times by Hoechst stain assay as 
described in Methods. Those values in the presence of light that are different from those 
in the dark with statistical significance (p<0.05) are marked with an asterisk (*).
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Figure 2.4.7: (A) The release o f cytochrome c from mitochondria during ODTSNO- 
induced SK-MEL-28 Human melanoma cells apoptosis under dark and light conditions. 
SK-MEL-28 Human melanoma cells were treated by ImM ODTSNO for 30 min; excess 
ODTSNO was then removed and changed back to fresh media. The cells were exposed to 
the light for 15 min and put back incubator for 24h; cytochrome c release was assayed by 
Western blot. (B) The corresponding band densities o f anti-cytotchtome c western blots.
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Figure 2.4.8: Activation of caspase-3 during ODTSNO-induced apoptosis. SK-MEL-28 
human melanoma cells were treated with ImM of ODTSNO liposome for 30min, Excess 
ODTSNO liposome was removed and cells were then exposed to light for 15min. The 
cells were then changed back to fresh medium and put back to incubator for 24h. Cells 
were harvested and cell extracts were obtained as described in Methods. Cytosolic 
extracts were incubated with the fluorogenic substrate Ac-DEVD-AFC, and the 
fluorescence o f AFC released on proteolytic cleavage by active caspase-3 was measured.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
9 0
2.5 Discussion
It has been suggested that NO has an important physiological role as an effector 
molecule in mediating macrophage-induced tumor cell cytotoxicity (Hibbs Jr., et al., 
1988; Stuehr et al., 1989). Cytotoxic tumor cells exhibit morphological features of 
apoptosis, such as membrane blebbing, chromatin condensation and membrane-bound 
apoptotic bodies. Therefore, in this regard, macrophage-derived NO inhibits neoplastic 
cell growth by leading to the apoptosis in target tumor cells (Albina et al., 1998). NO has 
been suggested to play an essential role in mediating photo-induced cell death in human 
maligant cells (Ali et al., 2003). Many of the studies have demonstrated that NO can 
induce apoptosis in various tumor cell lines such as murine mastocytoma cells (Kitaj ima 
et al., 1994), leukemia cells (Shami et al., 1998) etc.
It has been reported that one NO source for the induction o f apoptosis in tumor 
cell lines results from the endogenous NO produced from L-arginine via the NOS- 
catalyzed pathway or exogenous NO such as authentic NO gas and chemical NO-donor 
compounds. Most studies are performed with chemical NO donor compounds, especially 
RSNOs, since RSNOs are relatively stable storage forms of NO in biological systems 
(Kolb, 2000, Stamler et al., 1992a). RSNOs possess NO-like activities such as 
vasodilation (Myers et al., 1990) and antiplatelet properties (Radomski et al., 1992). It 
has been suggested that RSNOs can exert their biological functions through the release of 
NO produced by photochemical cleavage of the S-NO bond. For example, we have 
shown that photolysis o f GSNO with visible light resulted in enhanced cytotoxity to HL- 
60 leukemia cells (Sexton et al., 1994), suggesting that RSNOs could be used as 
photochemotherapeutic agents.
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In the present study, ODTSNO, a novel lipophilic RSNO, was synthesized to 
explore its apoptotic role in SK-MEL-28 human melanoma cells upon exposure to the 
light. The present results demonstrated that ODTSNO could result in cell death of SK- 
MEL-28 human melanoma cells in the dark by inducing the apoptosis, suggesting that 
ODTSNO was also subject to spontaneous release o f NO in the dark, probably due to the 
buffer contaminated with metal ions such as Cu2+ (Williams et al., 1996a) or thiol groups 
(Scorza et al., 1997) in the medium or cell surface PDI present in the cells 
(Ramachandran et al., 2001). However, apoptotic efficiency was substantially enhanced 
in the presence o f light, suggesting that ODTSNO could undergo photochemical cleavage 
to release higher concentrations of NO in the desired sites so as to increase the apoptotic 
efficiency, consistent with early conclusion that high levels of NO could cause self- 
destruction o f tumor cells (Xie et al., 1997).
But how does ODTSNO induce apoptosis in SK-MEL-28 human melanoma cells? 
Two pathways have been suggested to be responsible for the apoptosis (Zimmerman et 
al., 2002; Reed et al., 2000). One is death receptor-mediated apoptotic pathway; another 
is mitochondria-dependent apoptotic pathway. Apoptotic signalling pathways initiated by 
NO have been suggested to belong to a mitochondria-dependent apoptotic pathway. One 
typical feature of the mitochondria-dependent apoptotic pathway is the release of 
cytochrome c from mitochondria, which leads to caspase activation through the apoptotic 
protease-activating factor-1 (Apaf-1). Therefore, we want to examine whether apoptosis 
induced by ODTSNO in SK-MEL-28 human melanoma cells involves the release of 
cytochrome c. The present data demonstrated that cytochrome c was released during the 
apoptosis induced by ODTSNO under the dark and light conditions.
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Caspases, aspartate-directed cysteine proteases, are central to apoptosis 
(Hengartner, 2000). Caspase-3 is a well-characterized member of the effector caspases. 
Activation o f  caspase-3 has been proposed to be a key step in initiating the execution of 
apoptosis (Lin et al., 1998). Therefore, Caspase-3 activity was also examined in the 
present study during the apoptosis induced by ODTSNO. As a result, caspase-3 was 
activated, but the activity of caspase-3 is much higher in the presence o f the light than in 
the absence o f  the light.
Therefore, apoptosis induced by ODTSNO in SK-MEL-28 human melanoma cells 
involved the release of cytochrome c from mitochondria and caspase-3 activation.
In addition, compared with the known water-soluble RSNOs, ODTSNO is 
lipophilic. Thus, the effective concentration of NO released from ODTSNO could be 
enhanced with respect to the classical hydrophilic RSNO, because NO concentration in a 
hydrophobic compartment is approximately 9 times higher than that in aqueous solution 
(Liu et al., 1998). The short half-life of NO in aqueous solution can be attributed to the 
presence o f an active intermediate, N 2 O 3 , product of NO autooxidation, that is 
hydrolyzed to nitrite (Wink et al., 1998). However, lipophilic ODTSNO could rapidly 
accumulate in the membrane fraction. Thereby, higher concentrations of NO should 
remain in the membrane fraction after photolysis of ODTSNO. Higher concentrations of 
N2O3 should form in the membrane so as to initiate NO-mediated apoptotic signalling. 
Thus, the effective and actual concentration o f ODTSNO in apoptosis should be less than 
that of classical and hydrophilic RSNO such as GSNO. In this regard, lipophilic 
ODTSNO might be an effective anti-tumor photochemotherapeutic agent compared to the 
classical RSNOs.
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2.6 Conclusion
The present results demonstrated that novel and lipophilic ODTSNO could induce 
apoptosis in SK-MEL-28 human melanoma cells. The release of cytochrome c and 
caspase-3 activation was observed during the apoptosis induced by ODTSNO in SK- 
ME1-28 human melanoma cells. The apoptosis initiated by ODTSNO attributed to the 
NO released from ODTSNO. Furthermore, apoptotic efficiency is substantially enhanced 
approximately 30% upon exposure to the light. More cytochrome c was released in the 
presence of the light than in the absence of the light; the activity o f caspase-3 increased 
approximately 1.4 fold in the presence of light relative to dark condition. Therefore, the 
present study suggested that S-nitrosothiollipids might have the potential to be used as 
topical photochemotherapeutic agents for melanoma.
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